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Abstract
The heterogeneity of treatment effect (HTE) lies at the heart of precision medicine. Random-
ized clinical trials (RCTs) are gold-standard to estimate the HTE but are typically underpowered.
While real-world data (RWD) have large predictive power but are often confounded due to lack
of randomization of treatment. In this article, we show that the RWD, even subject to hid-
den confounding, may be used to empower RCTs in estimating the HTE using the confounding
function. The confounding function summarizes the impact of unmeasured confounders on the
difference in the potential outcome between the treated and untreated groups, accounting for
the observed covariates, which is unidentifiable based only on the RWD. Coupling the RCT and
RWD, we show that the HTE and confounding function are identifiable. We then derive the semi-
parametric efficient scores and integrative estimators of the HTE and confounding function. We
clarify the conditions under which the integrative estimator of the HTE is strictly more efficient
than the RCT estimator. As a by-product, our framework can be used to generalize the average
treatment effects from the RCT to a target population without requiring an overlap covariate
distribution assumption between the RCT and RWD. We illustrate the integrative estimators
with a simulation study and an application.
Keywords and phrases: Average treatment effect on the treated; Double machine learning;
Goodness of fit; Precision medicine; Semiparametric efficiency.
1 Introduction
Randomized clinical trials (RCTs) are the cornerstone of evidence-based medicine for treatment effect
evaluation, because randomization of treatment ensures that treatment groups are comparable and
biases are minimized to the extent possible. Recently, there is a considerable interest in understanding
the heterogeneity of treatment effect (HTE), a critical path toward personalized medicine (Hamburg
and Collins, 2010; Collins and Varmus, 2015). However, due to eligibility criteria for recruiting
patients, the RCT sample is often limited in patient diversity, which renders the trial underpowered
to estimate the HTE. On the other hand, real-world data (RWD) are increasingly available for
research purposes, such as electronic health records, claims databases, and disease registries, that
have much broader demographic and diversity compared to RCT cohorts. However, they also present
challenges such as confounding due to lack of randomization.
Existing approaches to harmonize evidences from RTCs and RWD include meta-analysis (Verde
and Ohmann, 2015) and joint analysis of the pooled data (Prentice et al., 2008). However, these
approaches assume no hidden confounders which are unlikely to be true in practice. Unmeasured
confounding presents a major threat to causal inference from RWD. The no unmeasured confounding
assumption requires researchers to measure all relevant predictors of treatment and outcome and ad-
just them properly in the analysis. However, it is always possible that certain important confounders
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are unavailable in uncontrolled real-world settings. For example, doctors used patient’s symptoms
that are not captured in the medical charts to assign treatments. Or certain prognostic factors are
measured with errors due to technological limitations. Unmeasured confounding renders the causal
effects of interest unidentifiable and can result in erroneous results in treatment effect estimation.
Classical approaches to mitigating bias due to unmeasured confounding include instrumental
variable methods (Angrist et al., 1996), negative controls (Kuroki and Pearl, 2014), and sensitivity
analysis (Robins et al., 1999). The selection of these methods for a study at hand highly depends
on the existence of variables satisfying certain properties. For example, instrumental variables are
related to the outcome only through the treatment, and negative outcome controls are influenced
by confounding variables but are not influenced by the treatment. Sensitivity analysis is often rec-
ommended to assess the robustness of the study conclusion to no unmeasured confounding. Many
authors have implemented sensitivity analysis using the so-called selection bias or confounding func-
tion (Robins et al., 2000; Yang and Lok, 2017; Kasza et al., 2017). Because the RWD carry no
information about confounding biases due to unmeasured confounders, the confounding function is
not identifiable based only on the RWD.
Instead of making the unrealistic no unmeasured confounding assumption, we consider confounded
RWD possibly subject to hidden confounders. We characterize the confounding function, namely the
difference of the potential outcome means between the treatment groups, by a pre-specified function
given the measured covariates. Importantly, the confounding function may be of independent interest
with applications beyond the present paper; see Section 7. In contrast to sensitivity analysis, we show
that the RCT can be leveraged to identify both the HTE and confounding function. Our method
depends on two key assumptions: transportability of the HTE and structural models of the HTE and
confounding function. Transportability of the HTE is a minimal assumption for data integration and
has been considered in a wide literature (e.g., Stuart et al., 2011; Buchanan et al., 2018; Dahabreh
et al., 2019). The confounding function is a new approach to handling unmeasured confounding. In
contrast to existing approaches such as instrumental variables, the confounding function approach
does not require variables with certain properties to exist and its specification is testable based on the
empirical data; see Section 7. Moreover, most existing methods for generalizing the treatment effect
from RCTs to a target population rely on the overlap assumption on the covariate distribution between
the RCT and RWD. However, this assumption is stringent, because RCTs often have strict inclusion
and exclusion criteria lending their underlying population different from the target population. Our
method does not require this assumption, which is advantageous.
The identification results motivate a wide class of unbiased estimating equations that can be used
to estimate the model parameters. However, naive choices of estimating equations lead to inefficient
estimators. To guide constructing efficient estimators and accelerate the full potential of RCTs
and RWD, we derive the semiparametric efficient score (SES) and the efficient influence function
(EIF) of the HTE and confounding function combining the two data sources. The theoretical task
is challenging because of induced restrictions on the parameters of interest from the identification
assumptions. To overcome the challenges, we translate the restrictions into the likelihood function
by re-parameterization and follow the geometric approach of Bickel et al. (1993) to derive the SES.
Based on the SES, we propose an integrative estimator of the HTE and confounding function, which
enable fast root-N rate of convergence, with weaker conditions on nuisance function approximation,
e.g. using flexible semiparametric and nonparametric methods. We also clarify the conditions under
which the gain of efficiency is non-zero by data integration over the RCT estimator.
Another line of research of combining RCTs and RWD is to generalize the average treatment
effects from RCTs to the target population (Stuart et al., 2015; Buchanan et al., 2018), where the
RWD provide a representative covariate distribution of the target population. As a by-product, we
derive the EIF and an efficient plug-in sample estimator of the population average treatment effect
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in the data integration context.
The rest of the paper is organized as follows. Section 2 describes the basic setup, the HTE and
confounding function, and a new identification framework. Section 3 develops improved estimation
of the HTE and confounding function based on semiparametric efficiency theory. Section 4 estab-
lishes the asymptotic properties of the integrative estimators combining the RCT and RWD, clarifies
conditions for strict efficiency gain by data integration, and develops improved estimation of the
population average treatment effects based on semiparametric efficiency theory. Section 5 evaluates
the finite sample performances of the proposed estimators in comparison with existing approaches.
Section 6 applies the proposed method to estimate the HTE of chemotherapy for non-small cell lung
cancer. Section 7 concludes with discussions and future directions. We sketch proofs of theorems in
the appendix and relegate details to the supplementary material.
2 Basic Setup and Identification
2.1 Notation, causal effects, and two data sources
Let A be the binary treatment, X be a vector of pre-treatment covariates with the first component
being 1, and Y be the outcome of interest. We use the potential outcomes (Neyman, 1923; Rubin,
1974) to define causal effects. Under the Stable Unit of Treatment Value assumption, let Y (a) be the
potential outcome had the subject been given treatment a, for a = 0, 1. By the causal consistency
assumption, the observed outcome is Y = Y (A) = AY (1) + (1−A)Y (0).
Based on the potential outcomes, the individual treatment effect is Y (1)−Y (0) and the heteroge-
neous treatment effect can be characterized through E[Y (1)−Y (0) | X] or E[Y (1)−Y (0) | A = 1, X],
where the expectation is taken with respect to the distribution of the target population. The former
denotes the conditional average effect of treatment in the sub-population with X when the whole
sub-population switches from the control to the active treatment, while the latter denotes the con-
ditional average effect of treatment in the sub-population with X who would be ultimately treated.
The choice of the estimand depends on the nature of the treatment and the research question. In
the cancer treatment context, not all individuals in the population are eligible for an intensive or
targeted cancer therapy. Also, in many cancer studies, there are barriers to placing a patient on
a given treatment, e.g., the patient should have no contraindications to the treatment. In these
contexts, E[Y (1)− Y (0) | A = 1, X] may be of greater interest than E[Y (1)− Y (0) | X]. Therefore,
we focus on τ(X) = E[Y (1) − Y (0) | A = 1, X] and the average treatment effect on the treated
τatt = E[τ(X) | A = 1].
In clinical settings, the parametric family of HTEs is desirable due to their easy interpreta-
tion. These models offer a transparent way of describing how the treatment effect varies across
patient’s characteristics and they can be used to tailor the treatment to an individual’s characteris-
tics (Chakraborty and Moodie, 2013). We make the following model assumption for the HTE.
Model Assumption 1. The HTE is
τ(X) = τϕ0(X), (1)
where ϕ ∈ Rp1 is a vector of unknown parameters.
Tian et al. (2014) and Shi et al. (2016) considered a linear HTE τψ0(X) = XTψ0, where the
first component of X is one, specifying an intercept term. This model entails that on average, the
treatment would increase the mean of the outcome by XTψ0, and the magnitude of the increase
depends on X. Moreover, each component of ψ0 quantifies the magnitude of the treatment effect of
each X. Assume that higher values are indicative of better outcomes. If XTψ0 > 0, it indicates that
the treatment is beneficial for the subject with X. Other flexible models can also be considered, such
as single-index models (Song et al., 2017) and multiple-index models (Chen et al., 2011).
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The target population consists of all patients with certain diseases where the new treatment
is intended to be given. We consider two independent data sources taken from the same target
population: one from the RCT and the other from the RWD. Let S = 1 denote RCT participation,
and let S = 0 denote RWD participation. The RCT data consist of {Vi = (Ai, Xi, Yi, Si = 1) : i ∈ A}
with sample size n, and the RWD consist of {Vi = (Ai, Xi, Yi, Si = 0) : i ∈ B} with sample size m,
where A and B are sample index sets for the two data sources. The sample size of the combined data
is thus N = n+m.
RCTs and RWD have complementary features. On the one hand, RCTs are often limited in
sample size and patient diversity, while RWD contain rich information on variations of the treatment
effect among a real-world patient population. On the other hand, RCTs involve treatment random-
ization and therefore different treatment groups are comparable due to similarity of their baseline
characteristics, while RWD are not designed for research purposes and therefore there are concerns
about confounding biases. In the following subsections, we establish the identification of the HTE
leveraging the design advantage of the RCT, and then formulate the confounding function in the
RWD that describes the impact of the unmeasured confounders.
2.2 Identification of the HTE using RCT
To simplify the exposition, define
e(X,S) = P(A = 1 | X,S), µ(X,S) = E[Y (0) | X,S], σ2(X,S) = V[Y (0) | X,S],
where e(X,S) is the treatment assignment probability, also known as the propensity score, µ(X,S) is
the outcome mean, and σ2(X,S) is the outcome variance. For any function g(V ), define the following
quantity
g(V ) = g(V )− E[g(V ) | X,S],
which is the residual of g(V ) by subtracting its conditional mean given (X,S). For example, A =
A− e(X,S) and Y (0) = Y (0)− µ(X,S).
Due to the fundamental problem in causal inference that the potential outcomes can never be
jointly observed for a particular subject, the HTE is not identifiable in general. We leverage the
design of the RCT to identify the HTE requiring the following assumptions.
Assumption 2 (Randomization and transportability). (i) Y (a) ⊥ A | (X,S = 1) for a ∈ {0, 1},
where ⊥ denotes “is independent of” (Dawid, 1979), and (ii) E[Y (1)−Y (0) | A = 1, X, S = 1] = τ(X)
for all RCT participants.
Assumption 2 (i) holds by a well-designed trial with good patient compliance. In clinical trials,
complete randomized treatment assignment schemes are rarely implemented in practice because it
can not rule out the possibility of the imbalance of treatment groups by chance alone. Assumption
2 (i) holds by the common trial designs such as stratified block randomization based on X, where
the treatment is independent of the potential outcomes within strata of X. Also, by design, the
propensity score e(X, 1) is known.
Assumption 2 (ii) is equivalent to E[Y (1)−Y (0) | X,S = 1] = τ(X). By the principle of equipoise
of clinical trials, trial participants must be eligible for both treatments, and thus by Assumption 2 (i)
we have E[Y (1)− Y (0) | A = 1, X, S = 1] = E[Y (1)− Y (0) | X,S = 1]. This assumption states that
the HTE is the same for the trial participants and the patient population at large (Stuart et al., 2011;
Buchanan et al., 2018; Dahabreh et al., 2019). It holds if trial participants are randomly recruited
for each subgroup of X, or the exclusion criteria of trial participation do not affect the treatment
response.
To establish the identification results, for the trial participants (S = 1), define
H = Y − τ(X)A. (2)
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Intuitively, H subtracts from the subject’s observed outcome Y the treatment effect of the subject’s
observed treatment τ(X)A, so it mimics the potential outcome under the control treatment Y (0).
Formally, as shown by Lok and DeGruttola (2012), E[H | A,X, S = 1] = E[Y (0) | A,X, S = 1].
Therefore, by Assumption 2 (i),
E[H | A,X, S = 1] = E[H | X,S = 1]. (3)
The mean exchangeability result in (3) is the key to the (local) identification/estimability of the HTE
parameter ϕ0. Based on the mean independence of H and A given (X,S = 1), for any c1(X), we
have
E[c1(X)SHA] = E[c1(X)SE[H | X,S]× E[A | X,S]] = 0
because E[A | X,S] = 0. Let Hϕ = Y − τϕ(X)A. We can construct an infinity number of unbiased
estimating functions of ϕ,
G1(A,X, Y, S;ϕ) = c1(X)SHϕA
= c1(X)S{Y − τϕ(X)A}{A− e(X,S)} (4)
for any c1(X). Therefore, subject to regularity conditions, ϕ0 is estimable from the RCT data.
Proposition 1 (Estimability of ϕ0). Under Assumptions 1 and 2, if the p1 components of ∂τϕ0(X)/∂ϕT
are not linearly dependent, i.e., there does not exist any one component of ∂τϕ0(X)/∂ϕT that can be
expressed as a linear combination of the remaining components almost surely, then ϕ0 is estimable.
Under the conditions in Proposition 1, by setting c1(X) = 1 in (4), E[∂G1(A,X, Y, S;ϕ0) /∂ϕ |
S = 1] has full rank p1 and therefore E[G1(A,X, Y, S;ϕ) | S = 1] = 0 has a unique solution ϕ0,
rendering ϕ0 estimable.
2.3 RWD: unmeasured confounding and confounding function
To leverage the rich information in the RWD, we make the following transportability assumption.
Assumption 3. E[Y (1)− Y (0) | A = 1, X, S = 0] = τ(X).
Assumption 3 is similar to Assumption 2 (ii); however, they have an important difference. As-
sumption 2 (ii) in fact applies to all trial participants by the principle of equipoise; while Assump-
tion 3 only applies to the patients who can ultimately take the treatment and does not require
E[Y (1) − Y (0) | A = 0, X, S = 0] = τ(X). Assumption 3 then states that the HTE for all patients
who can be exposed to the treatment is the same in the RWD and the target patient population. It
holds if X captures all treatment effect modifiers and requires the consultation of domain knowledge
to ensure its plausibility.
Unlike the RCT, the assumption of treatment randomization given X is typically unrealistic
for the RWD. As discussed in the introduction, we cannot rule out the possibility of unmeasured
confounders due to the uncontrolled treatment assignment mechanism in the RWD. To take into
account of the unmeasured confounders, we define the confounding function
λ(X) = E[Y (0) | A = 1, X, S = 0]− E[Y (0) | A = 0, X, S = 0].
In the absence of unmeasured confounders, we have E[Y (0) | A = 1, X, S = 0] = E[Y (0) | A =
0, X, S = 0] and therefore λ(X) = 0. In the presence of an unmeasured confounding variable U that
is related to both Y (0) and A after controlling for X, E[Y (0) | A = 1, X, S = 0] 6= E[Y (0) | A =
0, X, S = 0] and therefore λ(X) 6= 0. Thus, the confounding function λ(X) measures the impact of
unmeasured confounders on the potential outcome distribution between the treated and untreated
patients, accounting for the observed covariate X.
We make the following model assumption for the confounding function.
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Model Assumption 4. The confounding function is
λ(X) = λφ0(X), (5)
where φ ∈ Rp2 is a vector of unknown parameters.
The observed RWD alone carry no information about the confounding function because Y (0) for
the treated group is unknown. By harnessing a well-designed RCT, we show that φ0 is estimable
based on the combined RCT and RWD. For the RCT sample, we have seen that H = Y − τ(X)A
in (2) mimics Y (0) in the sense that they have the same conditional mean given (A,X, S = 1). A
natural question arises as to whether or not this property holds for the same construction of H in the
RWD sample. Unfortunately, the answer is “no” due to the unmeasured confounding in the RWD.
Explicitly, the difference of the conditional means of Y − τ(X)A and Y (0) is
E[Y − τ(X)A | A,X, S]− E[Y (0) | X,S] = E[Y (0) | A,X, S]− E[Y (0) | X,S]
= (1− S)λ(X)A, (6)
which is not zero if there exists an unmeasured confounder. Based on (6), our key insight is to define
Hψ0 = Y − τϕ0(X)A− (1− S)λφ0(X)A, (7)
where ψ = (ϕT, φT)T ∈ Rp (p = p1 + p2) is the full vector of model parameters in the HTE and
confounding function. For S = 1, (7) reduces to (2); for S = 0, we have an additional correction term
(1 − S)λφ0(X)A. It is this correction term that leads to E[H | A,X, S = 0] = E[Y (0) | X,S = 0],
which extends the property (3) to S = 0.
Theorem 1. Under Assumptions 1–4, for Hψ0 constructed by (7), we have
E[Hψ0 | A,X, S] = E[Hψ0 | X,S] = µ(X,S). (8)
For simplicity, we omit the dependence on the parameter value for quantities evaluated at the
true value if no ambiguity arises; e.g., H denotes Hψ0 . The mean exchangeability result in (8) is
the key to the estimability of ψ0. First, applying (8) with S = 1, the class of unbiased estimating
functions, G1(A,X, Y, S;ϕ) in (4) identifies ϕ0. Second, based on the mean independence of H and
A given (X,S = 0), for any c2(X), we have
E[c2(X)(1− S)HA] = E[c2(X)(1− S)E[H | X,S]× E[A | X,S]] = 0
because E[A | X,S] = 0. Therefore, we can construct an infinity number of unbiased estimating
functions of φ,
G2(A,X, Y, S;ψ) = c2(X)(1− S)Hψ0A
= c2(X)(1− S)[Y − τϕ0(X)A− (1− S)λφ0(X){A− e(X,S)}]{A− e(X,S)} (9)
for any c2(X). Therefore, subject to regularity conditions, φ0 is estimable from the combined RCT
and RWD.
Proposition 2 (Estimability of ψ0). Under Assumptions 1–4, suppose the identification condition
in Proposition 1 holds. Suppose further that the p2-vector of functions ∂λφ0(X)/∂φT are not linearly
dependent, i.e., there does not exist any one component of ∂λφ0(X)/∂φT that can be expressed as a
linear combination of the remaining components almost surely, then ψ0 = (ϕT0 , φ
T
0 )
T is estimable.
Under conditions in Proposition 2, by setting c1(X) = 1 in (4) and c2(X) = 1 in (9), E[∂G1(A,X, Y,
S;ϕ0)/∂ϕ | S = 1] has full rank p1 and E[∂G2(A,X, Y, S;ψ0)/∂φ | S = 0] has full rank p2, and there-
fore ψ0 is estimable.
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2.4 Algorithm for estimation
The identification result in Proposition 2 motivates the estimation of ψ0 based on estimating equa-
tions. Following the empirical process literature, let PN denote the empirical measure induced by
V1, . . . , VN ; i.e., PNG(V ) = N−1
∑N
i=1G(Vi) for any G(V ). Consider any measurable, bounded
c1(X) ∈ Rp1 and c2(X) ∈ Rp2 , an unbiased estimating equation of ψ0 is
PN
(
c1(X)
c2(X)(1− S)
)
HψA = 0. (10)
The solution to equation (10) is not feasible to calculate because it depends on the unknown dis-
tribution through the propensity score e(X,S). To facilitate using (10) for estimation, we require
positing a model for e(X,S) and estimate it from the data. We summarize the steps for estimating
ψ0 = (ϕ
T
0 , φ
T
0 )
T as follows.
Step 2.1. Using the data {(Ai, Xi, Yi, Si) : i ∈ A ∪ B}, fit a propensity score model, separately for
the two data sources, denoted by ê(X,S). For S = 1, one can simply take ê(X, 1) as the known
e(X, 1).
Step 2.2. Obtain ψ̂naiv = (ϕ̂Tnaiv, φ̂
T
naiv)
T by solving (10) with A replaced by its estimate ̂A =
A− ê(X,S).
The vast literature on unbiased estimating equations (van der Vaart, 2000) indicates that un-
der regularity conditions, ψ̂naiv is consistent and asymptotically normal for any choice of c(X) =
(c1(X)
T, c2(X)
T)T with the same dimension as ψ0. However, with a naive choice of c(X), the result-
ing estimator ψ̂naiv may have a large variability. The existence of an infinite number of estimators
necessitates a principled approach to developing efficient estimators of ψ0 in order to leverage the
maximum advantages of RCT and RWD samples. Toward this end, in the next session, we develop
the SES and semiparametric efficiency bound for ψ0.
3 Improve HTE Estimation based on Semiparametric Efficiency The-
ory
The naive estimators in Section 2.4 may not be efficient depending on the choice of c(X). The
semiparametric efficiency theory (Bickel et al., 1993) provides a principled approach to deriving
efficient estimators of the HTE and confounding function. In this session, we develop the SES and
semiparametric efficiency bound for ψ0.
The task is non-trivial for two reasons. Our semiparametric model consists of (i) models (1)
and (5) constituting the parametric part, and (ii) other components of the likelihood function con-
stituting the nonparametric part. First, Assumptions 2 and 3 impose restrictions on ψ0 as in (8);
second, the definition of Hψ0 relies on e(X,S); thus the parametric and nonparametric components
are interrelated. To overcome the challenges, we will use variable transformation from Y to Hψ0 and
translate the restrictions directly into the observed data likelihood function, leading to an uncon-
strained semiparametric likelihood function of ψ0; see (S6). Then, we use the geometric approach of
Bickel et al. (1993), following the road map in the Appendix, to derive the SES Seff,ψ0(V ).
Theorem 2 (SES of ψ0). Suppose Assumptions 1–4 hold. The SES of ψ0 is
Seff,ψ0(V ) = c
∗(A,X, S)WH,ψ0 , (11)
where
c∗(A,X, S) = E
[
∂H,ψ0
∂ψT
| A,X, S
]
− E
[
∂H,ψ0
∂ψT
W | X,S
]
E[W | X,S]−1,
H,ψ0 = Hψ0 − µ(X,S) and W = (V[H,ψ0 | A,X, S])−1.
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Theorem 2 provides a benchmark for gauging the efficiency of estimators of ψ0. From the SES,
the EIF of ψ0 is
EIFψ0(V ) = E[Seff,ψ0(V )S
T
eff,ψ0(V )]
−1Seff,ψ0(V ) (12)
with the variance Veff = (E[Seff,ψ0(V )STeff,ψ0(V )])
−1 achieving the semiparametric efficiency bound.
The SES (11) is complicated. We make a homoscedastic assumption that permits a simpler form
of SES and an easier comparison with the identification estimating equations (4) and (9).
Assumption 5. E[H2ψ0 | A,X, S] = E[H2ψ0 | X,S].
Assumption 5 extends the property of (8) from the first moment to the second moment. It holds
under the rank preserving condition (Robins, 1998; Zhang et al., 2011). The rank preserving condition
implies that Hψ0 equals Y (0), and therefore is more stringent than Assumption 5.
Theorem 3. Suppose Assumptions 1–5 hold. The SES of ψ0 is
Sψ0(V ) =
(
∂τϕ0 (X)
∂ϕ
∂λφ0 (X)
∂φ (1− S)
)
{σ2(X,S)}−1H,ψ0A. (13)
Compared with (4) and (9), the SES (13) suggests the optimal c1(X) is c∗1(X) = ∂τϕ0(X)/∂ϕ×
{σ2(X,S)}−1 and the optimal c2(X) is c∗2(X) = ∂λφ0(X)/∂φ × {σ2(X,S)}−1. Moreover, H,ψ0 =
Hψ0 −µ(X,S) in (13), by subtracting the conditional mean µ(X,S) from Hψ0 , reduces the variation
of Hψ0 in (4) and (9).
Theorem 3 motivates both statistically and computationally efficient estimators of ψ0. Again,
the SES depends on the unknown distribution through the nuisance functions ϑ = (e, µ, σ2), indi-
cating the propensity score e(X,S), the outcome mean µ(X,S), and the outcome variance σ2(X,S),
respectively. To overcome this issue, we posit models for the nuisance functions and solve the es-
timating equation of ψ0 with the approximated nuisance functions. To simplify the exposition,
we define the following quantities: Ĥψ = Y − τϕ(X)A − (1 − S)λφ(X)̂A; for any function g(V ),
̂g(V ) = g(V )− Ê[g(V ) | X,S], e.g., ̂A = A− ê(X,S) and ̂H,ψ = Ĥψ − µ̂(X,S). To emphasize their
dependence on the nuisance functions ϑ, we write Sψ(V ) in (13) as Sψ(V ;ϑ).
Besides the computational advantage, we provide another rationale for constructing estimators
based on Sψ0(V ) in Theorem 3 instead of Seff,ψ0(V ) in Theorem 2. Note that Sψ0(V ) involves a
product of the residuals H,ψ0 and A, but Seff,ψ0(V ) does not. Due to this feature, we will show
that the estimators based on Sψ0(V ) have a robustness property in Section 4. Before delving into
theoretical discussions, we summarize the proposed estimation procedure as follows.
Step 3.1. Using the data {(Ai, Xi, Yi, Si) : i ∈ A ∪ B}, fit a propensity score model, separately for
the two data sources, denoted by ê(X,S).
Step 3.2. Using the data {(Ai, Xi, Yi, Si) : i ∈ A ∪ B}, obtain a preliminary (consistent but may
not efficient) estimator ψ̂pre of ψ0 by solving (10) with c1(X) = c2(X) = X, i.e.,
PN
(
X
X(1− S)
)
Ĥψ ̂A = 0. (14)
Then, using the data {(Ai, Xi, Ĥψ̂pre,i, Si) : i ∈ A ∪ B}, fit an outcome model, separately for
the two data sources, denoted by µ̂(X,S).
Step 3.3. Obtain ψ̂ = (ϕ̂T, φ̂T)T by solving PNSψ(V ; ϑ̂) = 0, with σ2(X,S), H,ψ, and A replaced
by σ̂2(X,S), ̂H,ψ, and ̂A, respectively.
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Remark 1. In the above procedure, a preliminary estimator ψ̂pre is used in the approximation of
µ(X,S) = E[Hψ0 | X,S]. Step 3.3 then provides a one-step improvement estimator over ψ̂pre.
Alternatively, we can consider a different strategy that does not require a preliminary estimator. Let
µY (X,S) = E[Y | X,S]. It is easy to verify that
µ(X,S) = µY (X,S)− {τϕ0(X) + (1− S)λφ0(X)}A. (15)
Thus, approximating µ(X,S) amounts to approximating µY (X,S) and e(X,S) in A without requiring
a preliminary estimator.
We provide an example to elucidate a closed-form estimator under linear models. Consider
X = (XT1 , X
T
2 ), where X1 is k1-dimensional, and X2 is k2-dimensional. Consider the HTE to be
τϕ0(X) = X
Tϕ0 and the confounding function is λφ0(X) = XT1 φ0. Under the linear models, the
efficient HTE estimator is given explicitly as
ψ̂ = Γ̂−1
(
PNX{σ̂2(X,S)}−1̂Y ̂A
PN (1− S)X1{σ̂2(X,S)}−1̂Y ̂A
)
, (16)
and
Γ̂ =
(
PNXTX{σ̂2(X,S)}−1̂2A PN (1− S)XTX1{σ̂2(X,S)}−1̂2A
PN (1− S)XT1X{σ̂2(X,S)}−1̂2A PN (1− S)XT1X1{σ̂2(X,S)}−1̂2A
)
.
In general, the proposed estimator does not permit a closed-form solution; however, the solutions
to the estimating equations can be obtained by using the off-shelf software, e.g., the R function
“multiroot”.
4 Asymptotic properties
4.1 Robustness to slower rates for nuisance functions
It is well-known that estimators constructed based on EIFs are doubly robust in the sense that they
are consistent if either one of the parametric models for the nuisance functions is correctly specified
(Robins et al., 1994; Bang and Robins, 2005; Cao et al., 2009). More recently, many authors have
shown that doubly robust estimators possess a “rate double robustness” property (Rotnitzky et al.,
2019) in the sense that they retain a root-N convergence rate under weaker conditions on the flexible
models of the nuisance functions, such as semiparametric models, nonparametric models, and machine
learning algorithms (Chernozhukov et al., 2018).
The proposed integrative estimator depends on the estimation of the nuisance functions including
the outcome mean µ(X,S) and the propensity score e(X,S). As discussed in Remark 1, there are two
approaches to approximating µ(X,S): one based on Ĥψ with a preliminary estimator ψ̂pre in Step 3.2
and the other one based on (15). However, both approaches rely on a correct model for the propensity
score e(X,S). Although the proposed estimator capitalizes on EIFs, it relies on the correctness of
the propensity score model and therefore is not doubly robust. To protect the estimator from model
misspecification, we adopt data-adaptive methods to approximate the nuisance functions. We show
that under mild regularity conditions, the proposed estimator is rate doubly robust.
Suppose ϑ̂ = (ê, µ̂, σ̂2) include ê(X,S), µ̂(X,S), and σ̂2(X,S) that are general semiparametric or
nonparametric estimators of e(X,S), µ(X,S), and σ2(X,S), respectively. Let ϑ0 be the probability
limit of ϑ̂. For a vector v, we use ‖v‖2 = (v>v)1/2 to denote its Euclidean norm. For a function g(V ),
define Pg(V ) =
∫
g(v)dP(v) as the expectation of g(V ) under the true data-generating process. Also,
define the L2-norm as ‖g(V )‖ =
{∫
g(v)2dP(v)
}1/2 . By the empirical processes theory, we show that
the effect of nuisance parameter estimation in ψ̂−ψ0 is bounded by ‖ê(X,S)−e(X,S)‖2+‖ê(X,S)−
e(X,S)‖×‖µ̂(X,S)−µ(X,S)‖. If this bound is of rate oP(N−1/2), then it is asymptotically negligible,
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and thus ψ̂ is root-N consistent. The following theorem summarizes the regularity conditions and
asymptotic properties of ψ̂.
Theorem 4 (Rate double robustness). Suppose Assumptions 1–5 hold. Assume further the following
regularity conditions hold:
Condition 1. Sψ0(V ; ϑ̂) and Sψ0(V ;ϑ0) belong to a Donsker class of functions (van der Vaart and
Wellner, 1996).
Condition 2. (i) PN∂Sψ(V ;ϑ)/∂ψ exists and converges uniformly for ψ and ϑ in the neighborhoods
of their true values, and (ii) Ψ = E[∂Sψ0(V ;ϑ0)/∂ψ] is non-singular.
Condition 3. ||ψ̂ − ψ0|| = oP(1), ‖ê(X,S) − e(X,S)‖ = oP(1), and ‖µ̂(X,S) − µ(X,S)‖ = oP(1),
and |σ̂(X,S)| is uniformly bounded;
Condition 4. ‖ê(X,S)− e(X,S)‖2 + ‖ê(X,S)− e(X,S)‖×‖µ̂(X,S)− µ(X,S)‖ = oP(N−1/2).
Then, we have
N1/2(ψ̂ − ψ0)→ N
(
0, (Ψ−1)TE[Sψ0(V ;ϑ0)
⊗2]Ψ−1
)
, (17)
in distribution, as N → ∞. Moreover, the asymptotic variance of ψ̂ achieves the semiparametric
efficiency bound.
We discuss the implications of the regularity conditions. First, Condition 1 is standard for the
empirical processes. The Donsker class condition requires that the nuisance functions should not
be too complex. We refer the interested readers to Section 4.2 of Kennedy (2016) for a thorough
discussion of Donsker classes of functions. Relaxing this condition is possible by using the sample
splitting technique for estimation (Chernozhukov et al., 2018). Condition 2 is a standard condition in
the Z-estimation literature (van der Vaart, 2000). Condition 3 requires the estimators of the nuisance
functions to be consistent. This condition is fairly mild for semiparametric and nonparametric models.
Condition 4 states that the convergence rate of ê(X,S) to e(X,S) is of oP(N−1/4) and the combined
convergence rate of ê(X,S) to e(X,S) and µ̂(X,S) to µ(X,S) is of oP(N−1/2). This rate can occur
in various scenarios. For example, if both nuisance models are correctly specified parametric models,
both ‖ê(X,S) − e(X,S)‖ and ‖µ̂(X,S) − µ(X,S)‖ are OP(N−1/2) and their product is oP(N−1/2).
Under semiparametric and nonparametric models, if ‖ê(X,S)−e(X,S)‖ = oP(N−3/8) and ‖µ̂(X,S)−
µ(X,S)‖ = oP(N−1/8), then their product still achieves oP(N−1/2). However, the requirement for
the convergence rates is not symmetric for ê(X,S) and µ̂(X,S), because ê(X,S) is required to satisfy
||ê(X,S)−e(X,S)‖2= oP(N−1/2) but µ̂(X,S) is not. For example, if ‖ê(X,S)−e(X,S)‖ = oP(N−1/8)
and ‖µ̂(X,S) − µ(X,S)‖ = oP(N−3/8), Condition 4 does not hold. In general, there exist different
combinations of convergence rates of ê(X,S) and µ̂(X,S) that result in a negligible error bound
accommodating different smoothness conditions of the underlying true nuisance functions. Following
Lu et al. (2019) and Dong et al. (2020), we adopt generalized additive models for both e(X,S) and
µ(X,S), which can be carried out using off-the-shelf software, e.g., the “gam” function in R.
For variance estimation of ψ̂, we approximate the variance formula in (17) by replacing the analyt-
ical components with their estimated counterparts, and the expectations with the empirical averages.
Then, we can calculate Wald-type confidence intervals for the elements of ψ0. Because ψ̂ is regular
and asymptotically linear, the nonparametric bootstrap can also be used for variance estimation.
The bootstrap variance estimator is more straightforward to implement than the asymptotic approx-
imation. Thus, the bootstrap variance estimator is recommended in practice and adopted in the
simulation study.
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4.2 Efficiency gain of the HTE estimation by using the RWD
We now discuss the advantages of data integration. By Proposition 1, the RCT data grant a
consistent estimator of ϕ0. Denote the SES of ϕ0 applied to the RCT data be Srct,ϕ(V ;ϑ) =
S{∂τϕ(X)/∂ϕ}{σ2(X,S)}−1H,ϕA. Then, the RCT estimator ϕ̂rct can be obtained by solving
PNSrct,ϕ(V ; ϑ̂) = 0.
Theorem 5 shows that combining RCT and RWD has the advantage of gaining efficiency in the
estimation of ϕ0.
Theorem 5 (Efficiency gain by combining RCT and RWD). Suppose Assumptions 1–4 hold. The
asymptotic variance of ϕ̂ is equal to or less than the asymptotic variance of ϕ̂rct, with the equality
hold when
∂τϕ0(Xi)
∂ϕ
= M
∂λφ0(Xi)
∂φ
(18)
for some constant matrix M . Moreover, the gain in the asymptotic precision (i.e., the inverse of
asymptotic variance) is
{Va(ϕ̂)}−1 − {Va(ϕ̂rct)}−1 = m×
(
Ωϕϕ − ΩϕφΩ−1φφΩTϕφ
)
≥ 0, (19)
where Va denotes the asymptotic variance, and Ωab is a covariance matrix for a, b ∈ {ϕ, φ}.
Exact expressions of Ωab for a, b ∈ {ϕ, φ} are provided in the supplementary material. To gain
the intuition about Theorem 5, it is helpful to discuss two scenarios. If the confounding function is
known, Sψ(V ;ϑ) uses the additional RWD information (1− S){∂τϕ(X)/∂ϕ}{σ2(X,S)}−1H,ψA for
estimating ϕ0, comparing with Srct,ϕ(V ;ϑ); therefore, the integrative estimator ϕ̂ gains precision over
ϕ̂rct. Next, because the confounding function if unknown, the estimation of φ0 in the confounding
function competes the RWD information for the estimation of ϕ0. When (18) holds, the terms in
the confounding function and that in the HTE are collinear, and all RWD information is used to
estimate φ0. In this case, ψ̂ and ψ̂rct have the same asymptotic precision. When (18) does not hold,
the terms in the confounding function and that in the HTE are not entirely linearly dependent, and
the RWD information is used to estimate both φ0 and ϕ0. In this case, ψ̂ gains precision over ψ̂rct,
the magnitude of the gain increases with the sample size of the RWD.
4.3 Improve ATT estimation
The HTE characterizes individual variations of the treatment effect, while the ATT summarizes
the treatment effect for the target patient population at large. Because the RCT assigns treatments
randomly to the participants, τϕ0(X) is identifiable and can be estimated. However, the RCT samples
are known to be different from the real patient population due to the inclusion and exclusion criteria
for recruiting patients. Thus, the covariate distribution of the RCT sample f(X | S = 1) is different
from that of the target population f(X) in general. Consequently, E[τϕ0(X) | S = 1] is different
from τatt, and the ATT estimator using the RCT data only is biased of τatt generally.
Bridging the findings from a RCT to the target population has received generous interest in
the literature with different terms such as generalizability (Dahabreh et al., 2019), external validity
(Rothwell, 2005) or transportability (Pearl and Bareinboim, 2011). Most existing methods rely on
an overlap assumption that f(X | S = 1) and f(X) have the same support. This assumption may
not hold for cancer clinical trials, because older patients are often excluded for safety considerations.
On the other hand, the RWD samples are conceivably more representative of the real patient pop-
ulation because of the real-world data collection mechanisms. Formally, we formulate the following
assumption.
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Assumption 6. f(X | S = 0) = f(X).
It worth mentioning that we allow the support of f(X | S = 1) and f(X) to be different, and
hence by Assumption 6, we allow the RCT sample and the RWD sample to have non-overlapping
covariate distributions.
As a byproduct of the proposed data combination framework, under Assumption 6, we identify
the ATT by τatt = E[τϕ0(X)] = E[τϕ0(X) | S = 0]. The EIF of τatt is presented in the following
theorem.
Theorem 6 (EIF of τatt). Suppose Assumptions 1–6 hold. The EIF of τatt is
EIFatt(V ) =
1− S
pi0
{τϕ0(X)− τatt}+ E
[
∂τϕ0(X)
∂ϕT
∣∣∣∣S = 0]EIFϕ0(V ), (20)
where pi0 = P(S = 0) and EIFϕ0(V ) is the EIF of ϕ0, i.e, the first p1 components of EIFψ0(V ) in
(12).
Recall that ϕ0 is the parameter in the HTE, φ0 is the parameter in the confounding function,
and ψ0 = (ϕT0 , φT0 )T is the combined vector of parameters. From (12), EIFϕ0(V ) depends on φ0
in general. Although τatt depends only on ϕ0 in the HTE, EIFatt(V ) can depend on φ0 through
EIFϕ0(V ). From Theorem 6, the RWD not only provide a representative covariate distribution of
the target population but also can contribute to the estimation efficiency of τatt.
Once we obtain ϕ̂, a simple plug-in estimator of τatt is τ̂att = m−1
∑
i∈B τϕ̂(Xi). The following
theorem shows the rate double robustness and local efficiency of τ̂att.
Theorem 7. Suppose the assumptions in Theorem 4 and Assumption 6 hold. Then,
N1/2(τ̂att − τatt)→ N (0, Vatt) , (21)
in distribution, as N →∞, where
Vatt =
1
pi0
V [τϕ0(X) | S = 0] + ΨT0Ψ−1,TE[Sψ0(V ;ϑ0)⊗2]Ψ−1Ψ0.
Moreover, the asymptotic variance of τ̂att achieves the semiparametric efficiency bound.
5 Simulation study
We conduct a simulation study to evaluate the finite sample performance of the proposed estimators
of the HTE, confounding function, and ATT. For the RCT sample, the confounder is generated by
Xi ∼ Unif[−1, 1], the treatment is generated by Ai ∼ Bernoulli(0.5), and the unmeasured variable
is generated by Ui ∼ N(0, 1) for i = 1, . . . , n. For the RWD sample, the treatment is generated by
Ai ∼ Bernoulli(0.5), and the measured and unmeasured confounders (Xi, Ui) are generated from a
Gaussian mixture distribution(
Xi
Ui
)∣∣∣∣Ai ∼ N{( 10
)
,
(
1 Ai − 0.5
Ai − 0.5 1
)}
,
for i = n+ 1, . . . , n+m. Note that the distributions of Xi in the RCT sample and the RWD sample
do not overlap: one is a bounded uniform distribution and the other one is an unbounded normal
distribution.
For both RCT and RWD samples, the outcome is generated by
Yi = 1 +Xi + 0.5X
2
i +Ai(1 + 0.75X
2
i ) + 0.5Ui + 0.5i, (22)
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where i ∼ N(0, 1). Then the HTE is τ(Xi) = 1+0.75X2i , the confounding function is λ(Xi) = E[Ui |
Ai = 1, Xi]− E[Ui | Ai = 0, Xi] = −0.5 + 0.5Xi, and the ATT is τatt = E[τ(Xi) | Ai = 1] = 1.25.
We generate 1, 000 Monte Carlo samples with size n = 500 and m ∈ {500, 1000}. Simulation
results with larger n and m are presented in the supplementary material with similar conclusions. To
examine the impact of specifications of τ(Xi) and λ(Xi) on the efficiency of the proposed estimators,
we consider two specifications for τϕ:
(HTE-1) τϕ(Xi) = ϕ0 + ϕ2X2i , where ϕ = (ϕ0, ϕ2)
T;
(HTE-2) τϕ(Xi) = ϕ0 + ϕ1Xi + ϕ2X2i , where ϕ = (ϕ0, ϕ1, ϕ2)
T,
and three specifications for λφ:
(cf-1) λφ(Xi) = φ0 + φ1Xi, where φ = (φ0, φ1);
(cf-2) λφ(Xi) = φ0 + φ1Xi + φ2X2i , where φ = (φ0, φ1, φ2)
T;
(cf-3) λφ(Xi) = φ0 + φ1Xi + φ3X3i , where φ = (φ0, φ1, φ3)
T.
We consider the scenarios with HTE-1 and HTE-2 for various estimators:
“RCT”: ϕ̂rct using only the RCT data;
“Meta”: ϕ̂meta, meta-analysis of the combined RCT and RWD by regressing an inverse probability
weighting adjusted outcome Y adji = {ê(Xi, Si)}−1AiYi−{1− ê(Xi, Si)}−1(1−Ai)Yi on (1, X2i )
for HTE-1 and on (1, Xi, X2i ) for HTE-2. The rationale for ϕ̂meta is that in the absence of
unmeasured confounders, E[Y adji | Xi, Si] = τϕ0(Xi).
“Naive”: ϕ̂naiv solving (10) with the confounding function cf-1, which is used for comparison of the
efficiency of the proposed integrative estimator;
“Integr k”: ϕ̂k, the proposed integrative estimator based on the confounding function (cf-k) for
k = 1, 2, 3.
For the proposed estimator, there are 2 × 3 = 6 combinations of HTE-j and cf-k for j = 1, 2 and
k = 1, 2, 3. Under both HTE-1 and HTE-2, Condition (18) holds for cf-2, but it does not hold for
cf-1 and cf-3 with dim(φ) increasing from two to three. The consideration of HTE-1 and HTE-2 is
to assess whether the efficiency gain of the proposed estimator would be affected by the relationship
of dim(ϕ) and dim(φ). For all estimators, the nuisance functions are estimated under GAMs. We
implement the bootstrap for variance estimation with the bootstrap size 100.
Tables 1 and 2 present the simulation results with (n,m) = (500, 1000) for HTE-1 and HTE-2,
respectively. Figure 1 also displays the log ratios of the MSE of estimators compared to the MSE
of ϕ̂rct. Although the RCT estimator is unbiased for the HTE parameters, it is biased for τatt.
This is because the distribution of Xi differs from the trial sample and the overall population. The
meta-analysis that assumes no unmeasured confounding is biased of the HTE parameters and τatt,
due to the unmeasured confounding biases in the RWD. Consequently, the meta-analysis has low
coverage rates for all parameters of interest. All other estimators are unbiased for estimating the
model parameters and τatt. Comparing “Naive” and “Integr 1”, “Integr 1” has smaller MSEs for all
parameters for both HTE-1 and HTE-2, suggesting that using the semiparametric efficiency theory
offers a principled way to improve estimation efficiency. We now compare the integrative estimators
with the RCT estimators, under different specifications of the confounding function. For HTE-1, cf-2
satisfies (18); as a result, “Integr 2” performs similarly as ϕ̂rct for the HTE parameters. While cf-1
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Figure 1: Log ratio of MSE of estimator and MSE of ϕ̂rct: more negative values indicate more efficient
gains
14
and cf-3 do not satisfy (18); as a result, “Integr 1” and “Integr 3” have smaller MSEs than ϕ̂rct for the
HTE parameters. As m increases, the improvement using data integration increases. This confirms
our results in Theorem 5. For HTE-2, the above discussions remain the same; thus, the relationship
of dim(ϕ) and dim(φ) does not affect our conclusions. The proposed integrative estimators have
good coverage rates for all parameters. Moreover, all integrative estimators have smaller MSEs than
the RCT estimator for τatt due to the biased estimation based on RCT alone. Therefore, combining
RCT and RWD is advantageous to potentially improve the efficiency of the HTE estimation but also
the generalizability of the average treatment effect estimation.
In addition, the conclusions remain the same for the integrative estimators if the no unmeasured
confounding assumption indeed holds for the RWD; see the supplementary material for the additional
simulation.
6 Real data application
We apply the proposed estimators to evaluate the effect of adjuvant chemotherapy for early-stage
resected non-small cell lung cancer (NSCLC) using the CALGB 9633 trial data and a large clinical
oncology database – the national cancer database (NCDB). In CALGB 9633, 319 patients were
randomly assigned to observation versus chemotherapy, resulting 163 on observation (A = 0) and
156 on chemotherapy (A = 1). The comparable RW sample comes from the NCDB consisting of
15166 patients diagnosed with NSCLC between years 2004 – 2016 in stage IB disease with 10903 on
observation and 4263 received chemotherapy after surgery. As the treatments for the CALGB 9633
patients were randomly assigned and the treatments for the NCDB patients were chosen by physicians
and patients, the numbers of treated and controls are relatively balanced in the CALGB 9633 trial
while they are unbalanced in the NCDB. The outcome Y is the indicator of cancer recurrence within
3 years after the surgery.
We are interested in estimating the heterogeneous treatment effects of chemotherapy varying by
age and tumor size. The original CALGB 9633 trial analysis did not show any clinical improvement
for chemotherapy, possibly because of its small sample size (Strauss et al., 2008). Some exploratory
analysis however showed that tumor size may modify the treatment effect that patients with larger
tumor sizes may benefit more from the chemotherapy (Strauss et al., 2008, Speicher et al., 2015,
Morgensztern et al., 2016). Moreover, age may also be an important treatment effect modifier.
Therefore, we formulate the HTE of interest to be τψ(X) = ψ0 +ψ1× age∗+ψ2× tumor size∗, where
age∗ and tumor size∗ standardize age and tumor size by subtracting their means 67.7 and 4.8 and
dividing their standard errors 10.2 and 1.7, respectively, and ψ = (ψ0, ψ1, ψ2)T.
In the analysis, we include four covariates to adjust for in both samples: sex (1 = male, 0 =
female), histology (1 = squamous, 0 = non-squamous), and race (1 = White, 0 = others). Table 3
reports the covariate means by treatment group in the two samples. Due to treatment randomization,
all covariates are balanced between the treated and the control in the CALGB 9633 trial sample.
While due to a lack of treatment randomization, some covariates are highly unbalanced in the NCDB
sample. It can be seen that older patients with smaller tumor size and histology are likely to choose a
conservative treatment, on observation. Moreover, we can not rule out the possibility of unmeasured
confounders in the NCDB sample. To formulate the confounding function of the NCDB, possible
unmeasured confounders include disease status at diagnosis, financial status, and accessibility to
health care facilities that affect the decision of receiving adjuvant chemotherapy after surgery and
clinical outcomes. Therefore, we include gender, race, histology, Charlson co-morbidity score, income
level, insurance coverage, and travel range to large health care facilities in the confounding function,
as these variables have been shown to be related to the unmeasured confounders (Speicher et al.,
2015; Yang et al., 2016; Morgensztern et al., 2016; Speicher et al., 2017).
We compare the RCT, Meta, and proposed integrative estimators and estimate the standard
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Table 1: Simulation results under HTE-1 with n = 500 and m = 1000: “RCT” is ϕ̂rct using only
the RCT data, “Meta” is ψ̂meta based on meta-analysis of the combined datasets, “Naive” is ψ̂naiv
in (10) with confounding function (cf-1), and “Integr k” ϕ̂k the proposed integrative estimator with
the confounding function (cf-k) for 1 ≤ k ≤ 3; “yes” and “no” indicate (18) holds and does not hold,
respectively.
ϕ0 ϕ2 φ0 φ1 φ2 φ3 τatt
1 X2 1 X X2 X3
True (×102) 100 75 -50 50 0 0 250
Est (×102) RCT – 100 77 – – – – 125
Meta – 80 89 – – – – 257
Naive no 101 72 – – – – 245
Integr 1 no 100 75 -50 50 – – 250
Integr 2 yes 100 76 -50 50 -1 – 252
Integr 3 no 100 74 -50 50 – 1 247
Var (×103) RCT – 9 48 – – – – 4
Meta – 35 21 – – – – 16
Naive no 9 43 – – – – 121
Integr 1 no 4 3 7 11 – – 16
Integr 2 yes 9 48 12 10 51 – 140
Integr 3 no 7 33 11 14 – 6 106
VE (×103) RCT – 9 45 – – – – 4
Meta – 19 11 – – – – 13
Naive no 6 18 – – – – 58
Integr 1 no 4 3 8 9 – – 15
Integr 2 yes 9 46 13 8 49 – 136
Integr 3 no 7 31 12 13 – 6 97
Cvg (×102) RCT – 93.6 93.2 – – – – 0.0
Meta – 56.4 60.1 – – – – 85.8
Naive no 90.4 79.0 – – – – 82.2
Integr 1 no 94.8 92.5 94.7 93.1 – – 93.7
Integr 2 yes 93.6 93.1 93.8 92.8 93.6 – 93.4
Integr 3 no 95.9 96.0 94.5 93.7 – 95.0 95.4
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Table 2: Simulation results under HTE-2 with n = 500 and m = 1000: “RCT” is ϕ̂rct using only
the RCT data, “Meta” is ψ̂meta based on meta-analysis of the combined datasets, “Naive” is ψ̂naiv
in (10) with confounding function (cf-1), and “Integr k” ϕ̂k the proposed integrative estimator with
the confounding function (cf-k) for 1 ≤ k ≤ 3; “yes” and “no” indicate (18) holds and does not hold,
respectively.
ϕ0 ϕ1 ϕ2 φ0 φ1 φ2 φ3 τatt
1 X X2 1 X X2 X3
True (×102) 100 0 75 -50 50 0 0 250
Est (×102) RCT – 100 0 77 – – – – 125
Meta – 76 26 79 – – – – 260
Naive no 101 -0 72 – – – – 245
Integr 1 no 100 0 75 -51 50 – – 250
Integr 2 yes 100 0 76 -50 50 -2 – 253
Integr 3 no 100 0 75 -51 50 – -0 250
Var (×103) RCT – 9 12 48 – – – – 4
Meta – 21 101 65 – – – – 10
Naive no 9 14 43 – – – – 139
Integr 1 no 4 12 3 8 24 – – 28
Integr 2 yes 9 12 48 12 23 52 – 148
Integr 3 no 4 12 3 26 56 – 2 28
VE (×103) RCT – 9 12 46 – – – – 4
Meta – 12 52 35 – – – – 10
Naive no 6 13 18 – – – – 72
Integr 1 no 4 12 2 8 22 – – 29
Integr 2 yes 9 12 46 13 21 49 – 148
Integr 3 no 4 12 2 22 44 – 2 26
Cvg (×102) RCT – 93.5 95.6 93.1 – – – – 0.0
Meta – 41.7 68.1 79.4 – – – – 79.5
Naive no 89.9 93.9 78.9 – – – – 85.4
Integr 1 no 94.7 94.9 92.5 94.7 93.4 – – 94.4
Integr 2 yes 93.6 95.4 93.2 94.0 94.1 93.7 – 94.2
Integr 3 no 94.7 94.8 92.0 93.1 92.5 – 93.1 94.3
Table 3: Sample sizes and covariate means by treatment group in the CALGB 9633 trial sample and
the NCDB sample.
Age Tumor Size Male Squamous White
N A (years) (cm) (y/n) (y/n) (y/n)
RT: CALGB 9633 156 A=1 60.6 4.62 64.1% 40.4% 90.4%
163 A=0 61.1 4.57 63.8% 39.3% 88.3%
RW: NCDB 4263 A=1 63.9 5.19 54.3% 35.6% 88.6%
10903 A=0 69.4 4.67 54.8% 40.5% 90.0%
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Table 4: Point estimate, standard error and 95% Wald confidence interval of the model parameters
in the HTE function between adjuvant chemotherapy and observation based on the CALGB 9633
trial sample and the NCDB sample: age*= (age − 67.7)/10.2, tumor size*= (tumor size − 4.8)/1.7,
and all numbers are multiplied by 103
RCT Meta Integrative
Est SE 95% CI Est SE 95% CI Est SE 95% CI
1 ψ0 -46 63 (-169, 77) -89 8 (-105, -73) -94 52 (-196, 9)
age* ψ1 59 50 (-39, 158) -139 8 (-155, -123) -12 10 (-32, 8)
tumor Size* ψ2 -4 41 (-84, 77) 55 9 (38, 71) -22 9 (-39, -5)
errors by the nonparametric bootstrap. Table 4 reports the results for the estimated HTE parameters.
Due to the small sample size, the RCT estimators are not statistically significant. By pooling all
information from the CALGB 9633 and NCDB sample, the Meta and integrative estimators gain
efficiency and both show that the tumor size is a significant treatment effect modifier (95% CI for
ψ2 does not include zero). Interestingly, the two combining approaches produce different signs of ψ̂2
and hence different conclusions. The difference between the Meta and integrative estimators may
be attributable to the no unmeasured confounding. The Meta estimators assume that there are no
unmeasured confounders, while the integrative estimators take into account the possible unmeasured
confounders in the NCDB sample. The results in the supplementary material show that gender and
histology are significant in the confounding function, suggesting that the no unmeasured confounding
assumption is not plausible in the NCDB sample. We carry out the over-identification restrictions
test (Yang and Lok, 2016) to assess the goodness-of-fit of the HTE and confounding function; see
also Section 7. The test is directed at the alternative model specifications by augmenting HTE
and confounding function with (age∗2, tumor size∗2) and (age∗, tumor size∗), respectively. The test
statistics is 7.3 with p-value 0.12 based on a χ24 null reference distribution. Therefore, there is
no strong evidence to reject the model specifications of the HTE and confounding function in this
application. From the integrative approach, the tumor size is a significant treatment effect modifier:
larger tumor size, larger beneficial effect of chemotherapy in reducing the cancer recurrence.
7 Discussion
We develop a new semiparametric identification and estimation framework that combines RCT and
confounded RWD studies to assess the HTE. The RCT data identifies the HTE; however, we can
leverage the confounded RWD to improve estimation efficiency by modeling the confounding function
due to unmeasured confounding. The proposed integrative estimator capitalizes on semiparametric
efficiency and allows for flexible models for nuisance functions while retaining root-N consistency.
Moreover, we clarify conditions under which the integrative estimator gains efficiency over the es-
timator based solely on the RCT sample. The non-redundant structural form of the confounding
function is the key to achieve the efficiency gain. If strong prior information is available, appropriate
functional forms for the confounding function due to unmeasured confounding can be directly im-
posed. We suggest specifying the confounding function on the basis of observed data, literature, and
subject matter knowledge.
The model assumptions for the HTE and confounding function, i.e., Assumptions 1 and 4, are
crucial in our proposed framework. To evaluate the model specifications of the HTE and confounding
function, we can extend the goodness-of-fit test of Yang and Lok (2016). The insight is that we can
create a larger number of estimating functions than the number of parameters, which invokes the
application of over-identification restrictions tests (Sargan, 1988). For the power consideration, we can
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specify alternative plausible models for the HTE and confounding function. The optimal estimating
functions for constructing the test statistics can be derived based on Theorem 2 or Theorem 3 under
the alternative models.
Another potential application of the proposed framework is to estimate the trial encouragement
effect from an RCT study and an unconfounded RWD. In this article, we assume that the HTE is
transportable from the RCT sample to the RWD sample. Explicitly, we assume that the treatments
implemented in the trial and real-world settings are comparable given the relevant covariates. Several
authors have argued that the intervention in the trial often consists of the experimental treatment
and also additional planned or unplanned care that leads to the encouragement effect, which is absent
in the real-world setting. Assuming that the RWD are not subject to unmeasured confounding, the
proposed framework can be used to disentangle the pure treatment effect and the trial encouragement
effect. In this context, τϕ(X) denotes the total treatment and encouragement effect, and −λφ(X)
denotes the trial encouragement effect.
The RWD may have many more auxiliary variables than the RCT study. In this case, the con-
founding function can incorporate the additional auxiliary variables and even the observed outcome
variable. If X is high-dimensional, variable selection becomes important, because the estimating
equation approach may be unstable. Consider linear models τϕ(X) and λφ(X), the solution in (16)
involves inverting a high-dimensional matrix. To overcome the instability due to high-dimensional
covariates, in our future work, we can follow the penalized estimating equation approach by adding
penalties for ϕ and φ, which encourages sparsity.
Appendix
We sketch the proofs of Theorems 1–7 below and provide more details in the supplementary materials.
A1 Sketched Proof of Theorem 1
Proof. Given (6), it follows that
E[H | A,X, S] = E[Y −AE[Y (1)− Y (0) | A = 1, X, S] | A,X, S]
−E[{E[Y (0) | A,X, S]− E[Y (0) | X,S]} | A,X, S]. (A1)
Evaluating (A1) for A = 0, we obtain
E[H | A = 0, X, S] = E[Y (0) | A = 0, X, S]
− {E[Y (0) | A = 0, X, S]− E[Y (0) | X,S]} = E[Y (0) | X,S]. (A2)
Evaluating (A1) for A = 1, we obtain
E[H | A = 1, X, S] = E[Y (1)− Y (0) | A = 1, X, S]
− E[Y (1)− Y (0) | A = 1, X, S] + E[Y (0) | X,S] = E[Y (0) | X,S]. (A3)
Combining (A2) and (A3) yields E[H | A = 1, X, S] = E[H | A = 0, X, S]. Therefore, we have
E[H | A,X, S] = E[H | X,S].
A2 Sketched Proof of Theorem 2
We consider a regular asymptotically linear (RAL) estimator ψ̂ of ψ0:
N1/2(ψ̂ − ψ0) = N−1/2PN IF(V ) + oP(1), (A4)
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where IF(V ) is the influence function of ψ̂, which has zero mean and finite and nonsingular variance.
By (A4), the asymptotic variance of N1/2(ψ̂ − ψ0) is equal to the variance of IF(V ). Consider the
Hilbert space H of all p-dimensional, mean-zero finite variance measurable functions of V , h(V ),
equipped with the covariance inner product < h1, h2 >= E[h1(V )Th2(V )] and the L2-norm ||h||2 =
E[h(V )Th(V )] <∞. To construct the efficient estimator for ψ0, we follow the geometric approach of
Bickel et al. (1993) to derive the SES for ψ0 following the road map below.
We consider the density function of a single variable V = (A,X, Y, S), f(V ) = f(Y | A,X, S)f(A |
X,S)f(X,S). The parameter of interest ψ0 satisfies restriction (8) with H = Hψ0 , and the nuisance
parameter is the nonparametric density functions f(Y | A,X, S), f(A | X,S), and f(X,S). In
order to incorporate restriction (8) into the likelihood function directly, we consider an equivalent
re-parameterization, and re-express the semiparametric likelihood function; see (S6). Based on the
likelihood function, we characterize the nuisance tangent space Λ in the Hilbert spaceH; see Theorem
S1. We then express Λ as a direct sum of orthogonal subspaces; see Theorem S2. This effort will be
valuable in characterizing the orthogonal complement space of the nuisance tangent space Λ⊥, which
consists of all influence functions. Theorem A1 summarizes the key result.
Theorem A1 (Influence function space). Suppose Assumptions 1–4 hold. The space of the influence
function space of ψ0 is
Λ⊥ = {G(A,X, S;ψ0, c) = c(A,X, S)H,ψ0 : E[c(A,X, S) | X,S] = 0} . (A5)
Based on Theorem A1, we show that the projection of any B ∈ H, ∏[B | Λ⊥], is of the form
c(A,X, S)H,ψ0 , where E[c(A,X, S) | X,S] = 0. Let the score vector of ψ0 be sψ0(V ). Then, the SES
is the projection of sψ0(V ) onto Λ⊥, given by
Seff,ψ0(V ) =
∏[
sψ0(V ) | Λ⊥
]
= (E[sψ0(V )H,ψ0 | A,X, S]
−E[E[sψ0(V )H,ψ0 | A,X, S]W | X,S]E[W | X,S]−1
)
WH,ψ0 := c
∗(A,X, S)H,ψ0 .
To evaluate c∗(A,X, S) further, we note that E[H,ψ0 | A,X, S] = 0. We differentiate this equality
with respect to ψ0. By the generalized information equality (Newey, 1990), we have E[−∂H,ψ0/∂ψ |
A,X, S] + E[sψ0(V )H,ψ0 | A,X, S] = 0. Therefore, ignoring the negative sign, we have c∗(A,X, S)
as given by (11). This completes the proof of Theorem 2.
A3 Sketched Proof of Theorem 4
Proof. By the Taylor expansion, we have
0 = PNSψ̂(V ; ϑ̂) = PNSψ0(V ; ϑ̂) +
{
PN
∂S
ψ˜
(V ; ϑ̂)
∂ψT
}
(ψ̂ − ψ0)
= PNSψ0(V ; ϑ̂) + Ψ(ψ̂ − ψ0) + oP(N−1/2),
where ψ˜ lies in the line segment of ψ̂ and ψ0.
We now analyze PNSψ0(V ; ϑ̂). Under the conditions in Theorem 4, PSψ0(V ;ϑ0) = 0. Thus, we
have
PNSψ0(V ; ϑ̂)− PSψ0(V ;ϑ0)
= (PN − P)Sψ0(V ;ϑ0) + P{Sψ0(V ; ϑ̂)− Sψ0(V ;ϑ0)}+ oP(N−1/2)
= P{Sψ0(V ; ϑ̂)− Sψ0(V ;ϑ0)}+ oP(N−1/2), (A6)
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where the last equality follows because (PN −P)Sψ0(V ;ϑ0) = oP(N−1/2) for Sψ0(V ;ϑ0) belonging to
a Donsker class. We now show that under conditions in Theorem 4, P{Sψ0(V ; ϑ̂)− Sψ0(V ;ϑ0)} is a
small order term. For simplicity of exposition, write
c∗(X,S) =
(
∂τϕ0 (X)
∂ϕ
∂λφ0 (X)
∂φ (1− S)
)
.
Then, we have
P{Sψ0(V ; ϑ̂)− Sψ0(V ;ϑ0)}
=P
[
c∗(X,S){σ̂2(X,S)}−1{e(X,S)− ê(X,S)}{µ(X,S)− µ̂(X,S)}]
+ P
[
c∗(X,S){σ̂2(X,S)}−1(1− S)λφ(X){ê(X,S)− e(X,S)}2
]
.
By Cauchy-Schwarz inequality, ||Sψ0(V ; ϑ̂)− Sψ0(V ;ϑ0)|| is bounded above by
‖ê(X,S)− e(X,S)‖×‖µ̂(X,S)− µ(X,S)‖+ ‖ê(X,S)− e(X,S)‖2. (A7)
Under the conditions in Theorem 4, the bound (A7) is OP(N−1), which makes P{Sψ0(V ; ϑ̂) −
Sψ0(V ;ϑ0)} in (A6) asymptotically negligible. The result follows.
A4 Sketched Proof of Theorem 5
Proof. To simplify the exposition, let 2A,W = (A−E [AW | X,S]E[W | X,S]−1)2W denote a squared
weighted residual term of A. Define
Γ1,rct = E
[
S
{
∂τϕ0(X)
∂ϕ
}⊗2
2A,W
]
, Γ1,rwd = E
[
(1− S)
{
∂τϕ0(X)
∂ϕ
}⊗2
2A,W
]
,
Γ12 = E
[
(1− S)∂τϕ0(X)
∂ϕ
∂λφ0(X)
∂φT
2A,W
]
, Γ2 = E
[
(1− S)
{
∂λφ0(X)
∂φ
}⊗2
2A,W
]
.
We compare the asymptotic variance of ϕ̂rct and ϕ̂. By the Z-estimation theory, we obtain
V [ϕ̂− ϕ0] = N−1 ×
(
Γ1,rct + Γ1,rwd − Γ12Γ−12 ΓT12
)−1
+ o(n−1), (A8)
V [ϕ̂rct − ϕ0] = N−1 × Γ−11,rctΓ1,rctΓ−11,rct + o(n−1) = N−1 × Γ−11,rct + o(n−1). (A9)
By holder’s inequality, Γ1,rwd − Γ12Γ−12 ΓT12 is non-negative definitive; i.e., for any v ∈ Rp,
vT
(
Γ1,rwd − Γ12Γ−12 ΓT12
)
v ≥ 0,
with equality holds when (18) holds.
Comparing (A8) and (A9) leads to our result in Theorem 5.
A5 Sketched Proof of Theorem 6
Proof. Recall that pi0 = P(S = 0). We express τatt as
τatt = E[τϕ0(X)] = E[τϕ0(X) | S = 0] =
E[(1− S)τϕ0(X)]
pi0
. (A10)
To derive the EIF of τatt, we can follow a similar approach to derive the EIF of ψ0. Because τatt
depends on ϕ0 and EIFϕ0(V ) is available, we consider another approach. Consider a one-dimensional
21
parametric submodel, fθ(V ), which contains the true model f(V ) at θ = 0, i.e., fθ(V )|θ=0 = f(V ).
We use θ in the subscript to denote the quantity evaluated with respect to the submodel, e.g., τatt,θ
is the value of τatt with respect to the submodel. We use s(·) to denote the score function induced
from the likelihood function.
Recall that, the tangent space Λ is given in Theorem S2. The EIF for τatt, denoted by EIFatt(V ) ∈
Λ, must satisfy
τatt,θ/∂θ|θ=0 = E[EIFatt(V )s(V )].
We derive the EIF of τatt by calculating τatt,θ/∂θ|θ=0. This leads to EIFatt(V ) given by (20).
A6 Sketched Proof of Theorem 7
Proof. Let Ψ0 = E [∂τϕ0(X)/∂ϕ|S = 0] . By the Taylor expansion,
N1/2 (τ̂att − τatt) = N
1/2
m
∑
i∈B
{
τϕ̂(Xi)− τatt
}
=
N1/2
m
∑
i∈B
{τϕ0(Xi)− τatt}+
{
1
m
∑
i∈B
∂τϕ0(Xi)
∂ϕT
}
N1/2 (ϕ̂− ϕ0) + oP(1)
=
N1/2
m
∑
i∈B
{τϕ0(Xi)− τatt}+ Ψ0N1/2 (ϕ̂− ϕ0) + oP(1). (A11)
Because the two terms in (A11) are uncorrelated, we have
V
[
N1/2 (τ̂att − τatt)
]
= V
[
N1/2
m
∑
i∈B
{τϕ0(Xi)− τatt}
]
+ ΨT0V
[
N1/2 (ϕ̂− ϕ0)
]
Ψ0
=
1
pi0
V [τϕ0(X) | S = 0] + ΨT0V
[
N1/2 (ϕ̂− ϕ0)
]
Ψ0 = Vatt.
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Supplementary material for “Semiparametric efficient estimation of
heterogeneity of treatment effect combining trial and confounded real-
world evidence studies”
Section S1 provides the proof of Theorem 1. Sections S2 and S5 develop the semiparametric efficiency
theory of the HTE and the ATT, respectively. Section S3 provides the goodness-of-fit test of the HTE
and confounding function based on over-identification restrictions. Section S4 provides the proof of
Theorem 5. Sections S6 and S7 present additional results from the simulation and application.
S1 Proof of Theorem 1
Proof. To prove (8), we show that E[H | A,X, S = 0] does not depend on A. Toward this end, we
first show that
E[Y (0) | A,X, S = 0]− E[Y (0) | X,S = 0] = P(1−A | X,S = 0)(2A− 1)λ(X)
= P(1−A | X,S = 0)(2A− 1) {E[Y (0) | X,A = 1, S = 0]− E[Y (0) | X,A = 0, S = 0]} . (S1)
It suffices to show (S1) holds for both A = 0 and 1.
Considering (S1) for A = 0, the left hand side of (S1) becomes
E[Y (0) | A = 0, X, S = 0]− E[Y (0) | X,S = 0]
= E[Y (0) | A = 0, X, S = 0]− E[Y (0) | A = 0, X, S = 0]P(A = 0 | X,S = 0)
−E[Y (0) | A = 1, X, S = 0]P(A = 1 | X,S = 0)
= −P(A = 1 | X,S = 0) {E[Y (0) | A = 1, X, S = 0]− E[Y (0) | A = 0, X, S = 0]} ,
which is the right hand side of (S1) with A = 0.
Considering (S1) for A = 1, the left hand side of (S1) becomes
E[Y (0) | A = 1, X, S = 0]− E[Y (0) | X,S = 0]
= E[Y (0) | A = 1, X, S = 0]− E[Y (0) | A = 0, X, S = 0]P(A = 0 | X,S = 0)
−E[Y (0) | A = 1, X, S = 0]P(A = 1 | X,S = 0)
= P(A = 0 | X,S = 0) {E[Y (0) | A = 1, X, S = 0]− E[Y (0) | A = 0, X, S = 0]} ,
which is the right hand side of (S1) with A = 1. Therefore, (S1) holds.
It follows that for H, we have
E[H | A,X, S = 0] = E[Y −AE[Y (1)− Y (0) | A = 1, X, S = 0] | A,X, S = 0]
−E[P (1−A | X,S = 0)(2A− 1)λ(X) | A,X, S = 0]
= E[Y −AE[Y (1)− Y (0) | A = 1, X, S = 0] | A,X, S = 0]
−E[{E[Y (0) | A,X, S = 0]− E[Y (0) | X,S = 0]} | A,X, S = 0].
For A = 0, we obtain
E[H | A = 0, X, S = 0] = E[Y | A = 0, X, S = 0]
−{E[Y (0) | A = 0, X, S = 0]− E[Y (0) | X,S = 0]}
= E[Y (0) | A = 0, X, S = 0]
−{E[Y (0) | A = 0, X, S = 0]− E[Y (0) | X,S = 0]}
= E[Y (0) | X,S = 0]. (S2)
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For A = 1, we obtain
E[H | A = 1, X, S = 0] = E[Y − E[Y (1)− Y (0) | A = 1, X, S = 0] | A = 1, X, S = 0]
−E[{E[Y (0) | A = 1, X, S = 0]− E[Y (0) | X,S = 0]} | A = 1, X, S = 0]
= E[Y (1)− Y (0) | A = 1, X, S = 0]− E[Y (1)− Y (0) | A = 1, X, S = 0]
+E[Y (0) | X,S = 0]
= E[Y (0) | X,S = 0]. (S3)
Combining (S2) and (S3) leads to E[H | A = 1, X, S = 0] = E[H | A = 0, X, S = 0]. Therefore,
E[H | A,X, S = 0] = E[H | X,S = 0].
S2 The semiparametric efficiency theory of the HTE
S2.1 Re-parameterization of likelihood function
The density function of a single variable V = (A,X, Y, S) is f(V ) = f(Y | A,X, S)f(A | X,S)f(X,S).
The parameter of interest ψ0 satisfies restriction (8) with H = Hψ0 , and the nuisance parameter is
the nonparametric density functions f(Y | A,X, S), f(A | X,S), and f(X,S).
We consider an equivalent re-parameterization, in order to incorporate restriction (8) into the
likelihood function directly. Toward that end, we decompose H as follows:
H = H − E[H | A,X, S]︸ ︷︷ ︸
H=H(H,A,X,S)
+E[H | A,X, S]− E[H]︸ ︷︷ ︸
Q=Q(A,X,S)
+E[H], (S4)
where E[H | A,X, S] = 0, E[Q] = 0, and H and Q are squared integrable. Note that “squared
integrable” is a technical condition to ensure that the nuisance score vectors lie in the Hilbert space
H. Then, the semiparametric model defined by restriction (3) is equivalent to the following re-
parameterization
H = H + q(X,S)− E[q(X,S)] + E[H], E [H | A,X, S] = 0. (S5)
On the one hand, if restriction (8) holds, it implies Q depends only on (X,S), but not on A. Because
E[Q] = 0, we can then express Q = q(X,S)− E[q(X,S)] with q(X,S) a squared integrable function
of (X,S), so the re-parameterization (S5) exists. On the other hand, if H can be expressed in (S5),
H satisfies the restriction (3).
We can write the likelihood function based on a single variable V as
L(ψ, θ;V ) = f(Y | A,X, S)f(A | X,S)f(X,S)
= f(H | A,X, S)f(A | X,S)f(X,S)∂H
∂Y
= f(H | A,X, S)f(A | X,S)f(X,S), (S6)
where the last equality follows from
H = Y − τϕ0(X)A− (1− S)λφ0(X){A− e(X,S)}
−E[H]−
{
q(X,S)−
∫
q(X,S)f(X,S)dν(X,S)
}
,
with q(X,S) a nonparametric function of (X,S). Because E[H | A,X, S] = 0, we require
∫
Hf(H |
A,X, S)dν(H) = 0, where ν(·) is a generic measure. After re-parameterization, the nuisance param-
eter becomes the infinite dimensional set θ consisting of f(H | A,X, S), f(A | X,S), f(X,S), E[H],
and q(X,S).
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We assume all the regularity conditions to ensure the existence of the efficient score function of
ψ0 are satisfied, which are mainly continuity conditions for the parameter and the semiparametric
model; e.g., we need ψ = ψ(θ) to be pathwise differentiable with respect to θ (Bickel et al., 1993;
Tsiatis, 2006). These conditions are not restrictive for a typical application problem.
To distinguish nuisance parameters, we re-write the likelihood function as
L(ψ0, θ;V ) = f1(H | A,X, S)f5(A | X,S)f3(X,S), (S7)
where
H = Y − τϕ0(X)A− (1− S)λφ0(X){A− e(X,S)}
−c4 −
{
q2(X,S)−
∫
q2(X,S)f3(X,S)dν(X,S)
}
,
and θ = (θ1, . . . , θ5) consists of the nuisance parameters θ1 = f1(H | A,X, S), θ2 = q2(X,S),
θ3 = f3(X,S), θ4 = c4, and θ5 = f5(A | X,S). Then, H = H(ψ0, θ2, θ3, θ4, θ5) depends on the
parameter of interest ψ0 and the nuisance parameters (θ2, θ3, θ4, θ5). This order for indexing the
nuisance parameters makes the characterization of the nuisance tangent space easier.
Theorems S1 and S2 present the characterizations of the nuisance tangent space and its orthogonal
complement, respectively. The proofs are followed after stating these results.
Theorem S1. The nuisance tangent space corresponding to θ = (θ1, . . . , θ5) in model (3) is
Λ = Λ(1) + Λ(2) + Λ(3) + Λ(4) + Λ(5),
where Λ(j) is the nuisance tangent space with respect to θj, for j = 1, . . . , 5. Define Λ∗ = {Γ∗ =
Γ∗(X,S) ∈ Rp : E[Γ∗] = 0} and S = S(H , A,X, S) = ∂ log f1(H | A,X, S)/∂H ∈ R1 evaluated at
the truth. Then,
Λ(1) = {Γ(1) = Γ(1)(H , A,X, S) ∈ Rp : E[Γ(1) | A,X, S] = 0, and E[Γ(1)H | A,X, S] = 0},
Λ(2) = {Γ(2) = Γ(2)(H , A,X, S) = Γ(2)(Γ∗) = Γ∗S ∈ Rp : Γ∗ ∈ Λ∗},
Λ(3) = {Γ(3) = Γ(3)(H , A,X, S) = Γ(3)(Γ∗) = Γ∗ + E[QΓ∗]S ∈ Rp : Γ∗ ∈ Λ∗},
Λ(4) = {cS : S = S(H , A,X, S), c ∈ Rp},
Λ(5) =
{
Γ(5) = Γ(5)(A,X, S)− (1− S)λ(X)Γ(5)(X,S)S ∈ Rp : E[Γ(5)(A,X, S) | X,S] = 0,
Γ(5)(X,S) = e(X,S){1− e(X,S)}{Γ(5)(A = 1, X, S)− Γ(5)(A = 0, X, S)}
}
.
Here and throughout in a slight abuse of notation, we use Γ(2)(·) and Γ(3)(·) as functions of (H , A,X, S)
and also as operators on Γ∗, but their meaning should be clear in the context.
Remark S1. It is important to note that Γ(5)(A,X, S) with E[Γ(5)(A,X, S) | X,S] = 0 is orthogonal
to all other subspaces in Λ.
For simplicity, we define the following notation.
Definition S1. Let
W = W (A,X, S) = (V[H | A,X, S])−1, (S8)
T = T (X,S) = E[W | X,S], (S9)
0 = 0(H , A,X, S) = E[W | X,S]−1WH +Q, (S10)
T ∗ = E[T−1] = E[E[W | X,S]−1]. (S11)
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We now express Λ as a direct sum of orthogonal subspaces. This effort will be valuable in
characterizing the orthogonal complement space of the nuisance tangent space Λ⊥.
Theorem S2. The space Λ can be written as a direct sum of orthogonal subspaces:
Λ = Λ˜(1) ⊕ Λ˜(2) ⊕ Λ˜(3) ⊕ Λ˜(4) ⊕ Λ˜(5), (S12)
where ⊕ denotes a direct sum, and using the notation in Theorem S1 and Definition S1, Λ˜(1) = Λ(1),
Λ˜(2) =
{
Γ˜(2) = Γ˜(2)(Γ∗) = Γ∗WH : Γ∗ ∈ Λ∗
}
, (S13)
Λ˜(3) =
{
Γ˜(3) = Γ˜(3)(Γ∗) = Γ∗ − E[QΓ∗](T ∗T )−1WH : Γ∗ ∈ Λ∗
}
, (S14)
Λ˜(4) =
{
Γ˜(4) = c0 : c ∈ Rp
}
, (S15)
Λ˜(5) =
{
Γ˜(5) = Γ(5)(A,X, S) : E[Γ(5)(A,X, S) | X,S] = 0
}
. (S16)
S2.2 Proof of Theorem S1
Proof. For the semiparametric model (3), we specify the likelihood function as given by (S7). In the
following, we characterize the tangent space of θk for k = 1, . . . , 5.
For the nuisance parameter θ1, we require that (i) f1(H | A,X, S) is a nonparametric distribution,
and (ii)
∫
Hf1(H | A,X, S)dν(H) = 0 because E[H | A,X, S] = 0. This leads to a semiparametric
restricted moment model for θ1. Following Brown and Newey (1998), the tangent space of θ1 is Λ(1).
For the nuisance parameter θ2 in the likelihood through H = H(ψ0, θ2, θ3, θ4, θ5) only, the score
function is
Γ(2) = Γ(2)(H , A,X, S) = {∂ log f(H | A,X, S; θ1)/∂H}
× {−q˙2(X,S) +
∫
q˙2(X,S)f3(X,S)dν(X,S)},
where q˙2(X,S) is an arbitrary function of (X,S). In a different notation, the score function Γ(2)
can be written as Γ∗S, where S = ∂ log f(H | A,X, S; θ1)/∂H , Γ∗ = Γ∗(X,S) = −q˙2(X,S) +∫
q˙2(X,S)f3(X,S)dν(X,S), and E[Γ∗] = 0. Therefore, the tangent space of θ2 is Λ(2).
For the nuisance parameter θ3, the score function is
Γ(3) = Γ(3)(H , A,X, S) = Γ
∗ + {∂ log f1(H | A,X, S)/∂H} ×
∫
q2(X,S)Γ
∗dν(X,S)
= Γ∗ + {∂ log f1(H | A,X, S)/∂H} ×
∫
{q2(X,S)− E[q2(X,S)]}Γ∗dν(X,S)
= Γ∗ + {∂ log f1(H | A,X, S)/∂H} ×
∫
QΓ∗dν(X,S),
where Γ∗ = Γ∗(X,S) satisfies E[Γ∗] = 0, the second equality follows because E[Γ∗] = 0. In a different
notation, the score function Γ(3) is of the form Γ∗ + SE[QΓ∗]. Therefore, the tangent space of θ3 is
Λ(3).
For the nuisance parameter θ4 in the likelihood through H = H(ψ0, θ2, θ3, θ4, θ5) only, the
tangent space of θ4 is Λ(4).
For the nuisance parameter θ5, we require that (i) f5(A | X,S) = e(X,S)A{1− e(X,S)}1−A is a
nonparametric distribution, and (ii) H = H(ψ, θ2, θ3, θ4, θ5) depends on θ5 through e(X,S). Then,
the score function is
Γ(5)(A,X, S)− (1− S)λ(X)Γ(5)(X,S){∂ log f1(H | A,X, S)/∂H},
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where Γ(5)(A,X, S) ∈ Rp satisfies E[Γ(5)(A,X, S) | X,S] = 0, and Γ(5)(X,S) = e(X,S){1 −
e(X,S)}{Γ(5)(A = 1, X, S)−Γ(5)(A = 0, X, S)}. The relationship between Γ(5)(X,S) and Γ(5)(A,X, S)
is derived based on f5(A | X,S) = e(X,S)A{1− e(X,S)}1−A. Therefore, the tangent space of θ5 is
Λ(5).
S2.3 Remarks
Remark S2. Because S is the score vector with respect to f1(H | A,X, S), E[S | A,X, S] = 0. In
addition, because E[H | A,X, S] = 0, E[SH | A,X, S] = −1.
Remark S3. Because E[H | A,X, S] = 0,
W = (V[H | A,X, S])−1 = (E[2H | A,X, S])−1. (S17)
S2.4 Overview and Lemmas for the proof of Theorem S2
For l ≥ 1, let ⊕lk=1Λ˜(k) = Λ˜(1) ⊕ · · · ⊕ Λ˜(l) for orthogonal spaces Λ˜(1), · · · , Λ˜(l). To express Λ =∑5
k=1 Λ
(k) as a direct sum of orthogonal subspaces, we provide a road map: Define Λ˜1 = Λ1.
(i) Define Λ˜(2) ≡∏[Λ(2) | Λ˜(1),⊥]. We show that Λ˜(2) is the same as in (S13).
(ii) Define Λ˜(3) ≡∏[Λ(3) | (⊕2k=1Λ˜(k))⊥]. We show that Λ˜(3) is the same as in (S14).
(iii) Define Λ˜(4) ≡∏[Λ(3) | (⊕3k=1Λ˜(k))⊥]. We show that Λ˜(4) is the same as in (S15).
(iv) Define Λ˜(5) ≡∏[Λ(5) | (⊕4k=1Λ˜(k))⊥]. We show that Λ˜(5) is the same as in (S16).
To calculate these projections in the above process, we need the following Lemmas.
Lemma S1 (Normal equations). Let Λ be a subspace of a Hilbert space H equipped with an inner
product < ·, · >. Suppose that Λ is defined as Λ = {O(Γ),Γ ∈ H}, where O : H → H is a bounded
linear operator. Let O∗ be the adjoint of O, i.e., for any vectors h1, h2 ∈ H, < O(h1), h2 >=<
h1,O∗(h2) >. For a given vector B ∈ H, because
∏
[B | Λ] ∈ Λ, by the definition of Λ, there exists
Γ ∈ H such that ∏[B | Λ] = O(Γ). Then, Γ satisfies the normal equation O∗(B) = O∗O(Γ).
See, e.g., Weidmann (2012). Lemma S1 is useful to express a projection
∏
[B | Λ]. By Lemma S1,
we only need to find the unique Γ ∈ H that satisfies the normal equation. Then, ∏[B | Λ] = O(Γ).
Lemma S2. (a) For Γ∗S ∈ Λ(2), where S = ∂ log f1(H | A,X, S)/∂H , Γ∗ = Γ∗(X,S) and
E[Γ∗] = 0, we have
∏[
Γ∗S | Λ(1),⊥
]
= −Γ∗WH . (b) For cS, where c is a constant, we have∏[
cS | Λ(1),⊥
]
= −cWH .
Proof. To show (a), we can verify (i) Γ∗WH ∈ Λ(1),⊥; and (ii) Γ∗S + Γ∗WH ∈ Λ(1). Similarly, we
can show (b).
Lemma S3. For Γ(3)(Γ∗) ∈ Λ(3), ∏[Γ(3)(Γ∗) | Λ(1),⊥] = Γ∗ − E[QΓ∗]WH .
Proof. To show
∏[
Γ(3)(Γ∗) | Λ(1),⊥] = ∏[Γ∗ + SE[QΓ∗] | Λ(1),⊥] = Γ∗−E[QΓ∗]WH , we can verify
(i) Γ∗ − E[QΓ∗]WH ∈ Λ(1),⊥, and (ii) SE[QΓ∗] + E[QΓ∗]WH ∈ Λ(1).
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Lemma S4. Let D∗ = d∗(X,S), then∏[
D∗T−1WH | Λ˜(2),⊥
]
= E[D∗T−1](T ∗T )−1WH ,
where all the terms are defined in Theorem S2. In particular, by choosing D∗ = cT , where c is a
constant, we have ∏[
cWH | Λ˜(2),⊥
]
= c(T ∗T )−1WH .
Proof. For any Γ˜(2) ∈ Λ˜(2), we have Γ˜(2) = Γ˜(2)(Γ∗) = Γ∗WH . By definition of Γ∗, Γ∗ = Γ∗(X,S)
and E[Γ∗] = 0. Thus, Γ∗ can be written as O1(B) := E[B | X,S] − E[B], for some B = b(V ) ∈ H.
For convenience of notation, let O2(·) denote Γ˜(2)(·). We can show that the adjoint operators are
O∗1 = O1 and O∗2 = O2 Then, we can rewrite Γ˜(2) = O2O1(B), for some B = b(V ) ∈ H. The adjoint
operator of O := O2O1 is O∗ = O∗1O∗2 = O1O2.
By Lemma S1 with O = O2O1, we have∏[
D∗T−1WH | Λ˜(2)
]
= Γ∗WH , (S18)
where Γ∗ satisfies the normal equation:
O∗1O∗2O2O1(Γ∗) = O∗1O∗2(D∗T−1WH). (S19)
The solution Γ∗ to the normal equation (S19) is Γ∗ = T−1{D∗ − (T ∗)−1E[T−1D∗]}.
Finally, plugging in the expression of Γ∗ into (S18) proves Lemma S4.
Lemma S5. Let D = d(X,S) with E[D] = 0. Then,
∏[
D | Λ˜(3),⊥
]
= E[QD](V[0])−10.
Proof. For any Γ˜(3) ∈ Λ˜(3), we have Γ˜(3) = Γ˜(3)(Γ∗) = Γ∗−E[QΓ∗](T ∗T )−1WH , where Γ∗ = Γ∗(X,S)
and E[Γ∗] = 0. Thus, we can rewrite Γ˜(3) = O(B) for some B = b(V ) ∈ H, where O(B) = O3O1(B)
with O1(B) := E[B | X,S]−E[B] and O3(B) := Γ˜(3)(B). Similar in the proof of Lemma S4 , we can
show that O∗1 = O1. Moreover, for any B2 ∈ H,
O∗3(B2) = B2 − E[B2(T ∗T )−1WH ]Q. (S20)
Now by Lemma S1,
∏[
D | Λ˜(3)
]
= Γ˜(3)(Γ∗), where Γ∗ satisfies the normal equation:
O∗O(Γ∗) = O∗(D). (S21)
By the normal equation (S21), we then have D = Γ∗ + E[QΓ∗](T ∗)−1Q, which leads to
Γ˜(3)(Γ∗) = D − E[QΓ∗](T ∗)−10. (S22)
Therefore, from (S21), ∏[
D | Λ˜(3),⊥
]
= D − Γ˜(3)(Γ∗) = E[QD](V[0])−10,
where the second equality follows from (S22).
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Lemma S6. Let G = g(A,X, S), then∏[
GWH | (Λ˜(2) + Λ˜(3))⊥
]
= L1 + L2,
where L1 =
(
G− T−1E[GW | X,S])WH and L2 = G0(V[0])−10 with
G0 = E[GWT−1]. (S23)
Moreover, if G is not a function of A, then L1 = 0. In particular with G = Γ∗, which is not a
function of A, then ∏[
Γ∗WH | (Λ˜(2) + Λ˜(3))⊥
]
= 0.
Proof. Let Λ̂(2) ≡ {Γ̂(2)(B) = BWH : B = b(X,S)}. Because Λ˜(2) ⊂ Λ̂(2), we have Λ̂(2),⊥ ⊂ Λ˜(2),⊥.
We will show in the proof of Theorem S2 that any vector in Λ˜(2) is constructed as a projection onto
Λ˜(3),⊥, and therefore by construction, Λ˜(2)⊥Λ˜(3). Now, we can express∏[
GWH | (Λ˜(2) + Λ˜(3))⊥
]
=
∏[∏[
GWH | Λ̂(2),⊥
]
| Λ˜(3),⊥
]
︸ ︷︷ ︸
L1
+
∏[∏[∏[
GWH | Λ̂(2)
]
| Λ˜(2),⊥
]
| Λ˜(3),⊥
]
︸ ︷︷ ︸
L2
. (S24)
To evaluate L1, note that∏[
GWH | Λ̂(2)
]
= E[GW | X,S]T−1WH , (S25)
because (i) E[GW | X,S]T−1 is a function of (X,S), so E[GW | X,S]T−1WH ∈ Λ̂(2), and (ii) for
any Γ̂(2)(B) = BWH ∈ Λ̂(2), where B = b(X,S), E[{G − E[GW | X,S]T−1}WH × Γ̂(2)(B)] = 0.
Consequently,
L1 =
∏[
GWH −
∏[
GWH | Λ̂(2)
]
| Λ˜(3),⊥
]
=
∏[
GWH − E[GW | X,S]T−1WH | Λ˜(3),⊥
]
(S26)
= GWH − E[GW | X,S]T−1WH , (S27)
where the last equality follows because GWH − E[GW | X,S]T−1WH ∈ Λ˜(3),⊥.
To evaluate L2, we have
L2 =
∏[∏[∏[
GWH | Λ̂(2)
]
| Λ˜(2),⊥
]
| Λ˜(3),⊥
]
=
∏[
E[E[GW | X,S]T−1](T ∗T )−1WH | Λ˜(3),⊥
]
=
∏[
E[GWT−1](T ∗T )−1WH | Λ˜(3),⊥
]
:= E[GWT−1](V[0])−10 (S28)
where the first equality follows from (S25), the second equality follows by applying Lemma S4 with
D∗ = E[GW | X,S], and the last equality follows by applying the normal equation technique.
Together, (S24), (S27) and (S28) prove Lemma S6.
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S2.5 Proof of Theorem S2
Proof. We show (S12) step by step following the road map in Section S2.4.
First, we show that
∏[
Λ(2) | Λ˜(1),⊥
]
is the same as Λ˜(2) in (S13). By definition of Λ(2), for any
Γ(2) ∈ Λ(2), by Lemma S2, ∏[Γ(2) | Λ˜(1),⊥] = ∏[Γ∗S | Λ˜(1),⊥] = −Γ∗WH . Therefore, Λ˜(2) is given
by (S13).
Second, we show that
∏[
Λ(3) |
(
⊕2k=1Λ˜(k)
)⊥]
is the same as Λ˜(3) in (S14). For any Γ(3) =
Γ(3)(Γ∗) ∈ Λ(3), (a) by Lemma S3, we have ∏[Γ(3)(Γ∗) | Λ˜(1),⊥] = Γ∗ − E[QΓ∗]WH ; then (b) by
the fact that Γ∗⊥Λ˜(3),⊥ and ∏[Γ∗ − E[QΓ∗]WH | Λ˜(3),⊥] = Γ∗ − E[QΓ∗](T ∗T )−1WH by Lemma
S4. Therefore, Λ˜(3) is given by (S14).
Third, we show that
{∏[
Γ(4) |
(
⊕3k=1Λ˜(k)
)⊥]
: Γ(4) ∈ Λ(4)
}
is the same as Λ˜(4) in (S15). For any
cS ∈ Λ(4), (a) by Lemma S2,∏[cS | Λ˜(1),⊥] = −cWH ; then (b) by Lemma S6,∏[cWH | (Λ˜(2) ⊕ Λ˜(3))⊥] =
cT ∗(V[0])−10. Therefore, Λ˜(4) is given by (S15).
Finally, we show that
{∏[
Γ(5) |
(
⊕4k=1Λ˜(k)
)⊥]
: Γ(5) ∈ Λ(5)
}
is the same as Λ˜(5) in (S16). For
any Γ(5) ∈ Λ(5), by Lemma S7 in Section S2.6 below, we can show that (1 − S)λ(X)Γ(5)(X,S)S ∈(
⊕4k=1Λ˜(k)
)⊥
, so
∏[
Γ(5) |
(
⊕4k=1Λ˜(k)
)⊥]
= Γ(5)(A,X, S). Therefore, Λ˜(5) is given by (S16).
S2.6 Lemma S7 and its proof
For simplicity, we define the following notation.
Definition S2. Let
B˙ = B˙(H , A,X, S) = B − E[B | A,X, S], (S29)
B∗ = B∗(X,S) = E[B | X,S]− E[B], (S30)
R = R(A,X, S) = E[BH | A,X, S]. (S31)
Lemma S7. Following the notation in Definitions S1 and S2, for any B = b(V ),∏[
B |
(
⊕4k=1Λ˜(k)
)⊥]
=
(
R− T−1E[RW | X,S])WH . (S32)
To compute
∏[
B |
(
⊕4k=1Λ˜(k)
)⊥]
, decompose B into
B = B − E[B | A,X, S]︸ ︷︷ ︸
B˙=B˙(H ,A,X,S)
+E[B | A,X, S]− E[B | X,S]︸ ︷︷ ︸
B(2)=B(2)(A,X,S)
+E[B | X,S]− E[B]︸ ︷︷ ︸
B∗=B∗(X,S)
.
By Remark S1, we have
∏[
B(2) |
(
⊕4k=1Λ˜(k)
)⊥]
= 0. By Lemma S5,
∏[
B∗ |
(
⊕4k=1Λ˜(k)
)⊥]
= 0.
It then suffices to obtain
∏[
B˙ |
(
⊕4k=1Λ˜(k)
)⊥]
in (S32) in the following steps:
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Step 1. We show that
∏[
B˙ | Λ(1),⊥
]
= E[BH | A,X, S]WH using the following two facts: (i)
E[BH | A,X, S]WH ∈ Λ(1),⊥, and (ii) B˙ − E[BH | A,X, S]WH ∈ Λ(1).
Step 2. We show that∏[
E[BH | A,X, S]WH | (Λ˜(2) + Λ˜(3))⊥
]
=
∏[
RWH | (Λ˜(2) + Λ˜(3))⊥
]
= (R− T−1E[RW | X,S])WH + E[RWT−1](V[0])−10,
where first equality follows by the definition of R in (S31), and the second equality follows from
Lemma S6.
Step 3. Because (R − T−1E[RW | X,S])WH ⊥ Λ˜(4) and E[RWT−1](V[0])−10 ∈ Λ˜(4), we have∏[
B˙ |
(
⊕4k=1Λ˜(k)
)⊥]
= (R− T−1E[RW | X,S])WH .
S2.7 Proof of Theorem A1
Proof. By Lemma S7, for any B = b(V ),∏[
B | Λ⊥
]
=
∏[∏[
B |
(
⊕4k=1Λ˜(k)
)⊥] | Λ˜(5),⊥]
=
∏[
R− T−1E[RW | X,S])WH | Λ˜(5),⊥
]
= R− T−1E[RW | X,S])WH ,
where the last equality follows by Remark S1. Therefore,
∏[
B | Λ⊥] is of the form c(A,X, S)H ,
with c(A,X, S) =
(
R− T−1E[RW | X,S]) and E[c(A,X, S) | X,S] = 0.
S2.8 Proof of Theorem 3
Proof. We first write
c∗(A,X, S) =
(
E
[
∂H,ψ0
∂ψT
| A,X, S
]
− E
[
∂H,ψ0
∂ψT
| X,S
])
,
=
(
E
[
∂H,ψ0
∂ψT
| A = 1, X, S
]
− E
[
∂H,ψ0
∂ψT
| A = 0, X, S
])
{A− e(X,S)} .
Now based on (7), we have
∂H,ψ0
∂ψ
= −
(
∂τϕ0 (X)
∂ψ {A− e(X,S)}
(1− S)∂λφ0 (X)∂φ {A− e(X,S)}
)
,
and thus
E
[
∂H,ψ0
∂ψ
| A = 1, X, S
]
− E
[
∂H,ψ0
∂ψ
| A = 0, X, S
]
= −
(
∂τϕ0 (X)
∂ψ
(1− S)∂λφ0 (X)∂φ
)
.
This completes the proof.
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S3 Goodness-of-fit test using over-identification restrictions
The model assumptions for the HTE and confounding function, i.e., Assumptions 1 and 4, are crucial
in our proposed framework. In this section, we extend the goodness-of-fit test of Yang and Lok (2016)
to evaluate the model specifications of the HTE and confounding function based on over-identification
restrictions tests.
The insight is that we can create a larger number of estimating functions than the number of
parameters. Let c1(X) ∈ Rq1 and c2(X) ∈ Rq2 be some functions of X that are different from c∗1(X)
and c∗2(X), where q1, q2 > 0. As with (13), it is easy to show that
Gψ0(V ) =
(
c1(X)
c2(X)(1− S)
)
H,ψ0A (S33)
is unbiased. As a result, the number of unbiased estimating functions is larger than the dimension
of ψ0, resulting in over-identification restrictions. Under Assumptions 1 and 4, combining the unbi-
asedness of Gψ0(V ) and the consistency of ψ̂, we expect that the sample quantity PNGψ̂(V ) to be
close to zero. We show that
N−1/2PNGψ̂(V ) = N
−1/2PN {Gψ0(V ) + ΓTSψ0(V )}+ oP(1),
where Γ = −{E [∂Sψ0(V )/∂ψ]}−1 E [∂Gψ0(V )/∂ψ]. Therefore, N−1/2PNGψ̂(V ) is asymptotically
normal with mean 0 and variance ΣGG = V[Gψ0(V ) + ΓTSψ0(V )].
Based on the above results, we construct a goodness-of-fit test statistic
T =
{
PNGψ̂(V )
}T
Σ̂−1GG
{
PNGψ̂(V )
}
,
where Σ̂GG is a consistent estimator of ΣGG. Theorem S3 provides the reference distribution to gauge
the plausibility of the values T takes.
Theorem S3. Suppose Assumptions 1–5 hold. We have T → χ2q , a Chi-square distribution with
degrees of freedom q = q1 + q2, in distribution, as n→∞.
Let χ2q,α be the (1 − α) quantile of χ2q . From Theorem S3, if T < χ2q,α, there is no significant
evidence to reject the model specifications of the HTE and confounding function, and if T ≥ χ2q,α,
there is strong evidence to reject the model specifications.
The choice of c1(X) and c2(X) determines the power of the goodness-of-fit test. For the power
consideration, we can specify alternative plausible models for the HTE and confounding function.
Theorem 3 provide the optimal c1(X) and c2(X) under the alternative models. We then adopt this
choice for the goodness-of-fit test.
S4 Proof of Theorem 5
Proof. We express the SES as Seff,ψ0 = c∗(A,X, S) (Hψ0 − E[Hψ0 | X,S]) with Hψ0 = Y −τϕ0(X)A−
(1− S){A− e(X,S)}λφ0(X). First, we have
Hψ0 − E[Hψ0 | X,S] = Y − E[Y | X,S]− τϕ0(X){A− e(X,S)} − (1− S){A− e(X,S)}λφ0(X),
c∗(A,X, S) =
(
E
[
∂H,ψ0
∂ψT
| A,X, S
]
− E
[
∂H,ψ0
∂ψT
W | X,S
]
E[W | X,S]−1
)
W
=
(
∂τϕ0 (X)
∂ϕ
(1− S)∂λφ0 (X)∂φ
)(
A− E [AW | X,S]E[W | X,S]−1)W,
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and W = (V[H,ψ0 | A,X, S])−1.
We compare the asymptotic variance of ϕ̂rct and ϕ̂. To simplify the proof, define the following
expression:
Γ1,rct = E
[
S
{
∂τϕ0(X)
∂ϕ
}⊗2 (
A− E [AW | X,S]E[W | X,S]−1) {A− e(X,S)}W] ,
= E
[
S
{
∂τϕ0(X)
∂ϕ
}⊗2 (
A− E [AW | X,S]E[W | X,S]−1)AW]
−E
[
S
{
∂τϕ0(X)
∂ϕ
}⊗2 (
AW − E [AW | X,S]E[W | X,S]−1W ) e(X,S)]
= E
[
S
{
∂τϕ0(X)
∂ϕ
}⊗2 (
A− E [AW | X,S]E[W | X,S]−1)2W] ,
Γ1,rwd = E
[
(1− S)
{
∂τϕ0(X)
∂ϕ
}⊗2 (
A− E [AW | X,S]E[W | X,S]−1)2W] ,
Γ1 = Γ1,rct + Γ1,rwd,
Γ12 = E
[
(1− S)∂τϕ0(X)
∂ϕ
∂λφ0(X)
∂φT
(
A− E [AW | X,S]E[W | X,S]−1)2W] ,
Γ2 = E
[
(1− S)
{
∂λφ0(X)
∂φ
}⊗2 (
A− E [AW | X,S]E[W | X,S]−1)2W] .
Also, we denote
SN,1(ψ) = N
−1 ∑
i∈A∪B
∂τϕ(Xi)
∂ϕ
(
Ai − E [AW | Xi, Si]E[W | Xi, Si]−1
)
Wi
× (Yi − E[Yi | Xi, Si]− τψ(Xi) {Ai − e(Xi, Si)} − (1− Si)λφ(Xi) {Ai − e(Xi, Si)}) ,
and
SN,2(ψ) = N
−1 ∑
i∈A∪B
∂λφ(Xi)
∂φ
(1− Si)
(
Ai − E [AW | Xi, Si]E[W | Xi, Si]−1
)
Wi
× (Yi − E[Yi | Xi, Si]− τψ(Xi) {Ai − e(Xi, Si)} − (1− Si)λφ(Xi) {Ai − e(Xi, Si)}) .
Then,
V [SN,1(ψ0)] = N−1 × Γ1, V [SN,2(ψ0)] = N−1 × Γ2, cov [SN,1(ψ0), SN,2(ψ0)T] = N−1 × Γ12. (S34)
By the Taylor expansion, we have
ψ̂ − ψ0 =
(
Γ1 Γ12
ΓT12 Γ2
)−1(
SN,1(ψ0)
SN,2(ψ0)
)
+ oP(n
−1/2)
=
(
Σ1 Σ12
ΣT12 Σ2
)(
SN,1(ψ0)
SN,2(ψ0)
)
+ oP(n
−1/2), (S35)
where (
Σ1 Σ12
ΣT12 Σ2
)
=
(
Γ1 Γ12
ΓT12 Γ2
)−1
.
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Equivalently, we have
Σ1Γ1 + Σ12Γ
T
12 = Ip×p, (S36)
Σ1Γ12 + Σ12Γ2 = 0p×p, (S37)
and therefore,
Σ1Γ1 + Σ12Γ
T
12 = Ip×p,
Σ1Γ12Γ
−1
2 Γ
T
12 + Σ12Γ
T
12 = 0p×p. (S38)
By (S38), we can solve Σ1 =
(
Γ1 − Γ12Γ−12 ΓT12
)−1.
Now continuing from (S35), we have
ϕ̂− ϕ0 = Σ1SN,1(ψ0) + Σ12SN,2(ψ0) + oP(n−1/2),
and therefore,
V [ϕ̂− ϕ0] = Σ1V [SN,1(ψ0)] Σ1 + Σ12cov [SN,2(ψ0), SN,1(ψ0)T] Σ1
+Σ1cov [SN,1(ψ0), SN,2(ψ0)T] Σ12 + Σ12V [SN,2(ψ0)] Σ12 + o(n−1).
Then, by (S34), we have
V [ϕ̂− ϕ0] = N−1 × (Σ1Γ1Σ1 + Σ12ΓT12Σ1
+ Σ1Γ12Σ12 + Σ12Γ2Σ12) + o(n
−1)
= N−1 × Σ1 + 0 + o(n−1) (S39)
= N−1 × (Γ1 − Γ12Γ−12 ΓT12)−1 + o(n−1)
= N−1 × (Γ1,rct + Γ1,rwd − Γ12Γ−12 ΓT12)−1 + o(n−1), (S40)
where (S39) follows by (S36) and (S37).
For the SES based only on the RCT data, we denote
SN,1,rct(ψ) = N
−1 ∑
i∈A∪B
Si
∂τϕ(Xi)
∂ϕ
(
Ai − E [AW | Xi, Si]E[W | Xi, Si]−1
)
Wi (Yi − E[Yi | Xi, Si]) .
Then,
V [SN,1,rct(ψ0)] = N−1 × Γ1,rct.
By the Taylor expansion, we have
V [ϕ̂rct − ϕ0] = N−1 × Γ−11,rctΓ1,rctΓ−11,rct + o(n−1) = N−1 × Γ−11,rct + o(n−1). (S41)
By holder’s inequality, Γ1,rwd − Γ12Γ−12 ΓT12 is non-negative definitive; i.e., for any v ∈ Rp,
vT
(
Γ1,rwd − Γ12Γ−12 ΓT12
)
v ≥ 0,
with equality holds when ∂τϕ0(Xi)/∂ϕ = M∂λφ0(Xi)/∂φ holds for some constant matrix M .
Comparing (S40) and (S41) leads to our result in Theorem 5.
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S5 The semiparametric efficiency theory of the ATT
S5.1 Preliminary
Recall that pi0 = P(S = 0). We express τatt as
τatt = E[τϕ0(X)] = E[τϕ0(X) | S = 0] =
E[(1− S)τϕ0(X)]
pi0
. (S42)
To derive the EIF of τatt, we can follow a similar approach in Section S2. Because τatt depends on
ϕ0 and EIFϕ0(V ) is available, we consider another approach. Consider a one-dimensional parametric
submodel, fθ(V ), which contains the true model f(V ) at θ = 0, i.e., fθ(V )|θ=0 = f(V ). We use θ in
the subscript to denote the quantity evaluated with respect to the submodel, e.g., τatt,θ is the value
of τatt with respect to the submodel. We use dot to denote the partial derivative with respect to θ,
e.g., τ˙att,θ = τatt,θ/∂θ, and use s(·) to denote the score function induced from the likelihood function.
Recall that, the tangent space Λ is given in Theorem S2. The EIF for τatt, denoted by EIFatt(V ) ∈
Λ, must satisfy
τ˙att,θ|θ=0 = E[EIFatt(V )s(V )].
We will derive the EIF by calculating τ˙att,θ|θ=0. To simplify the proof, we introduce some lemmas.
Lemma S8. Consider a ratio-type parameter R = N/D. If N˙θ|θ=0 = E[EIFN (V )s(V )] and D˙θ|θ=0 =
E[EIFD(V )s(V )], then R˙θ|θ=0 = E[EIFR(V )s(V )] where
EIFR(V ) =
1
D
EIFN (V )− R
D
EIFD(V ). (S43)
In particular, if EIFN (V ) and EIFD(V ) are the EIFs for N and D, then EIFR(V ) is the EIF for R.
Proof. Let Rθ, Nθ andDθ denote the quantities R, N , andD evaluated with respect to the parametric
submodel fθ(V ). By the chain rule, we have
R˙θ
∣∣∣
θ=0
=
N˙θ
D
∣∣∣∣∣
θ=0
−Rθ D˙θ
D
∣∣∣∣∣
θ=0
=
1
D
E[EIFN (V )s(V )]− R
D
E[EIFD(V )s(V )]
= E
[{
1
D
EIFN (V )− R
D
EIFD(V )
}
s(V )
]
,
which leads to (S43).
S5.2 Proof of Theorem 6
Proof. We derive the EIF for τatt. Given (S42), we can write τatt = N/pi0, where N = E[(1 −
S)τϕ0(X)]. By Lemma S8, the key is to derive the EIFs for N and pi0. By chain rule, we have
N˙θ |θ=0 = E[(1− S)τϕ0(X)s(X,S)] + E[(1− S)τ˙ϕ0,θ(X) |θ=0]
= E[{(1− S)τϕ0(X)−N}s(V )] + E
[
(1− S)∂τϕ0(X)
∂ϕT
]
ϕ˙0,θ |θ=0
= E[{(1− S)τϕ0(X)−N}s(V )] + E
[
(1− S)∂τϕ0(X)
∂ϕT
]
E[EIFϕ0(V )s(V )]
= E
[{
(1− S)τϕ0(X)−N + E
[
(1− S)∂τϕ0(X)
∂ϕT
]
EIFϕ0(V )
}
s(V )
]
.
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It is easy to verify that (1 − S)τϕ0(X) − N ∈ Λ(3). Also, by construction, we have EIFϕ0(V ) ∈ Λ.
Therefore, we derive the EIF for N as
EIFN (V ) = (1− S)τϕ0(X)−N + E
[
(1− S)∂τϕ0(X)
∂ϕT
]
EIFϕ0(V ).
By chain rule, we have
p˙i0,θ |θ=0= E[(1− S)s(S)] = E[(1− S − pi0)s(V )].
It is easy to verify that 1− S − pi0 ∈ Λ(3). Therefore, we derive the EIF for pi0 as
EIFpi0(V ) = 1− S − pi0.
Applying Lemma S8 yields the EIF for τatt as
EIFatt(V ) =
1
pi0
EIFN (V )− τatt
pi0
EIFpi0(V )
=
(1− S)τϕ0(X)
pi0
− τatt + E
[
1− S
pi0
∂τϕ0(X)
∂ϕT
]
EIFϕ0(V )
−τatt
pi0
(1− S − pi0)
=
1− S
pi0
{τϕ0(X)− τatt}+ E
[
∂τϕ0(X)
∂ϕT
∣∣∣∣S = 0]EIFϕ0(V ).
S5.3 Proof of Theorem 7
Proof. Let Ψ0 = E [∂piϕ0(X)/∂ϕ|S = 0] . By the Taylor expansion, we have
N1/2 (τ̂att − τatt) = N
1/2
m
∑
i∈B
{
τϕ̂(Xi)− τatt
}
=
N1/2
m
∑
i∈B
{τϕ0(Xi)− τatt}+
{
1
m
∑
i∈B
∂τϕ0(Xi)
∂ϕT
}
N1/2 (ϕ̂− ϕ0) + oP(1)
=
N1/2
m
∑
i∈B
{τϕ0(Xi)− τatt}+ Ψ0N1/2 (ϕ̂− ϕ0) + oP(1). (S44)
Because the two terms in (S44) are uncorrelated, we have
V
[
N1/2 (τ̂att − τatt)
]
= V
[
N1/2
m
∑
i∈B
{τϕ0(Xi)− τatt}
]
+ ΨT0V
[
N1/2 (ϕ̂− ϕ0)
]
Ψ0
=
1
pi0
V [τϕ0(X) | S = 0] + ΨT0V
[
N1/2 (ϕ̂− ϕ0)
]
Ψ0.
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S6 Additional simulation
S6.1 Additional simulation study with larger sample sizes
We consider the same simulation setting as in Section 5 but with larger sample sizes.
First, to reflect the sample sizes in real data application, we set the sample sizes n = 500 and
m = 5000. Tables S1 and S2 present the simulation results under HTE-1 and HTE-2, respectively.
Compared with the results in the main text, Integr 1 and Integr 3 have larger gains in estimation
efficiency due to a larger sample size of the RWD. Other conclusions remain the same.
Second, to demonstrate the results in Theorem 5, we set the sample sizes (n,m) = (5000, 2500)
and (n,m) = (5000, 5000). Table S3 reports the precision difference between the integrative estimator
and the RCT estimator. When (18) holds, the mean squared errors of ϕ̂ and ϕ̂rct are very close,
regardless of the specifications for the confounding function. When (18) does not hold, ϕ̂ has a
notably smaller variance than ϕ̂rct in all scenarios with dim(φ) <dim(ϕ), dim(φ) =dim(ϕ), and
dim(φ) >dim(ϕ). For these scenarios, the gain doubles if m doubles, as calculated in Table S3, which
is in line with the results in Theorem 5.
S6.2 No unmeasured confounding
In this simulation study, we consider the same simulation setting as in Section 5, except that we omit
Ui in (22), leading to a scenario without unmeasured confounding in the RWD.
Table S4 illustrates the simulation results under HTE-1 and HTE-2 in the absence of no un-
measured confounders. Similar discussions in Section 5 apply to the integrative estimators. Without
unmeasured confounding, the meta-analysis is unbiased but has larger variability than the integrative
estimators. The coverage rates are off the nominal level for the meta-analysis but are close to the
nominal level for the integrative estimators.
S7 Additional results from the application
Table S5 reports the results of the model parameters in the confounding function. Both φ̂1 and φ̂2
are significant, suggesting that the no unmeasured confounding assumption may not hold for the
NCDB sample.
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Table S1: Simulation results under HTE-1 with n = 500 and m = 5000: “RCT” is ϕ̂rct using only
the RCT data, “Meta” is ψ̂meta based on meta-analysis of the combined datasets, “Naive” is ψ̂naiv
in (10) with confounding function (cf-1), and “Integr k” ϕ̂k the proposed integrative estimator with
the confounding function (cf-k) for 1 ≤ k ≤ 3; “yes” and “no” indicate (18) holds and does not hold,
respectively.
ϕ0 ϕ2 φ0 φ1 φ2 φ3 τatt
1 X2 1 X X2 X3
True (×102) 100.0 75.0 -50.0 50.0 0.0 0.0 250.0
Est (×102) RCT – 99.9 77.0 – – – – 125.6
Meta – 70.6 91.0 – – – – 252.5
Naive no 100.4 74.3 – – – – 249.1
Integr 1 no 100.5 75.0 -50.5 50.1 – – 250.3
Integr 2 yes 99.9 76.8 -49.9 50.1 -1.8 – 253.4
Integr 3 no 100.5 75.0 -50.5 50.1 – 0.0 250.3
Var (×103) RCT – 8.7 46.2 – – – – 4.2
Meta – 0.5 0.1 – – – – 1.2
Naive no 5.1 7.9 – – – – 27.3
Integr 1 no 4.2 0.6 5.1 2.1 – – 6.2
Integr 2 yes 8.8 46.7 9.8 1.8 47.3 – 136.7
Integr 3 no 4.5 2.7 5.3 2.1 – 0.5 12.1
VE (×103) RCT – 9.0 46.3 – – – – 4.1
Meta – 0.6 0.1 – – – – 1.3
Naive no 4.4 3.7 – – – – 15.0
Integr 1 no 4.0 0.5 4.8 1.8 – – 6.0
Integr 2 yes 9.0 46.4 9.8 1.4 47.0 – 134.2
Integr 3 no 4.3 2.5 5.0 1.8 – 0.4 11.7
Cvg (×102) RCT – 94.9 94.5 – – – – 0.0
Meta – 0.0 0.0 – – – – 91.1
Naive no 92.7 79.9 – – – – 85.6
Integr 1 no 94.3 92.6 94.5 94.9 – – 94.2
Integr 2 yes 94.8 94.6 95.1 95.5 94.4 – 94.1
Integr 3 no 94.1 94.8 94.6 94.6 – 93.2 93.9
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Table S2: Simulation results under HTE-2 with n = 500 and m = 5000: “RCT” is ϕ̂rct using only
the RCT data, “Meta” is ψ̂meta based on meta-analysis of the combined datasets, “Naive” is ψ̂naiv
in (10) with confounding function (cf-1), and “Integr k” ϕ̂k the proposed integrative estimator with
the confounding function (cf-k) for 1 ≤ k ≤ 3; “yes” and “no” indicate (18) holds and does not hold,
respectively.
ϕ0 ϕ1 ϕ2 φ0 φ1 φ2 φ3 τatt
1 X X2 1 X X2 X3
True (×102) 100.0 0.0 75.0 -50.0 50.0 0.0 0.0 250.0
Est (×102) RCT – 99.9 0.7 77.1 – – – – 125.6
Meta – 59.4 40.9 76.9 – – – – 254.0
Naive no 100.5 0.2 74.3 – – – – 249.3
Integr 1 no 100.5 0.6 75.0 -50.5 49.5 – – 251.0
Integr 2 yes 99.8 0.6 76.9 -49.9 49.5 -1.9 – 254.2
Integr 3 no 100.5 0.6 75.0 -50.5 49.5 – 0.0 251.0
Var (×103) RCT – 8.7 11.7 46.0 – – – – 4.2
Meta – 0.6 1.1 0.2 – – – – 1.2
Naive no 5.1 14.1 7.9 – – – – 43.2
Integr 1 no 4.2 11.8 0.7 5.1 13.9 – – 17.5
Integr 2 yes 8.8 11.7 46.6 9.8 13.5 47.3 – 147.4
Integr 3 no 4.5 11.8 2.8 5.3 13.9 – 0.5 24.4
VE (×103) RCT – 9.0 12.2 46.4 – – – – 4.1
Meta – 0.6 1.1 0.2 – – – – 1.3
Naive no 4.4 13.3 3.7 – – – – 28.8
Integr 1 no 4.0 12.2 0.5 4.8 13.9 – – 18.1
Integr 2 yes 9.0 12.2 46.5 9.8 13.6 47.1 – 146.2
Integr 3 no 4.3 12.2 2.6 5.0 13.9 – 0.4 24.3
Cvg (×102) RCT – 94.9 95.4 94.9 – – – – 0.0
Meta – 73.1 – – – – 81.8
Naive no 92.7 94.5 80.0 – – – – 90.5
Integr 1 no 94.4 95.6 92.1 94.1 95.7 – – 95.4
Integr 2 yes 94.8 95.6 94.9 94.2 95.6 94.5 – 94.6
Integr 3 no 94.2 95.6 95.1 94.0 95.6 – 93.2 95.5
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Table S3: Simulation results of the precision difference between the integrative estimator and the
RCT estimator with n = 5000 and m ∈ {2500, 5000}: “Integr k” ϕ̂k the proposed integrative es-
timator based on the bis function (cf-k) for 1 ≤ k ≤ 3, the numerical number is 1/MSE(“Integr
k”)-1/MSE(“RCT”) where “RCT” ϕ̂rct using only the RCT data; “yes” and “no” indicate (18) holds
and does not hold, respectively.
m = 2500 m = 5000
ϕ0 ϕ1 ϕ2 τatt ϕ0 ϕ1 ϕ2 τatt
1 X X2 1 X X2
Integr 1 no 475 – 1108 514 494 – 2204 685
HTE-1 Integr 2 yes -0 – 0 151 -0 – -0 159
Integr 3 no 475 – 1127 518 493 – 2200 685
Integr 1 no 475 0 1110 529 509 0 2228 700
HTE-2 Integr 2 yes -0 0 -0 149 -0 0 -0 157
Integr 3 no 477 0 1128 531 508 0 2225 699
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Table S4: Simulation results under HTE-1 and HTE-2 with (n = 500, m = 5000) in the absence
of no unmeasured confounders: “RCT” is ϕ̂rct using only the RCT data, “Meta” is ψ̂meta based on
meta-analysis of the combined datasets, “Naive” is ψ̂naiv in (10) with confounding function (cf-1), and
“Integr k” ϕ̂k the proposed integrative estimator with the confounding function (cf-k) for 1 ≤ k ≤ 3;
“yes” and “no” indicate (18) holds and does not hold, respectively.
HTE-1 HTE-2
ϕ0 ϕ2 τatt ϕ0 ϕ1 ϕ2 τatt
1 X2 1 X X2
True (×102) 100.0 75.0 250.0 100.0 0.0 75.0 250.0
Est (×102) RCT – 100.1 75.9 125.3 100.0 0.5 76.0 125.4
Meta – 100.3 74.8 249.9 100.1 0.8 74.5 249.9
Naive no 100.4 74.3 248.9 100.4 -0.0 74.3 248.9
Integr 1 no 100.3 74.9 250.1 100.3 0.4 74.9 250.6
Integr 2 yes 100.1 75.8 251.5 100.0 0.4 75.9 252.1
Integr 3 no 100.3 75.0 250.2 100.3 0.4 74.9 250.5
Var (×103) RCT – 4.3 22.4 2.2 4.3 5.8 22.5 2.2
Meta – 12.8 4.8 1.6 4.8 31.9 16.5 1.3
Naive no 3.1 7.9 24.9 3.1 8.2 7.9 35.1
Integr 1 no 2.2 0.4 3.8 2.2 5.7 0.4 9.9
Integr 2 yes 4.4 22.4 66.2 4.4 5.8 22.5 73.4
Integr 3 no 2.3 1.5 7.0 2.2 5.7 0.4 9.8
VE (×103) RCT – 4.5 23.2 2.1 4.5 6.2 23.3 2.1
Meta – 7.8 2.9 1.4 2.8 21.4 10.5 1.2
Naive no 2.4 3.6 12.8 2.4 7.3 3.6 20.6
Integr 1 no 2.0 0.3 3.4 2.0 6.1 0.3 9.6
Integr 2 yes 4.5 23.2 67.3 4.5 6.2 23.3 73.5
Integr 3 no 2.2 1.4 6.6 2.0 6.1 0.3 9.5
Cvg (×102) RCT – 95.2 94.8 – 95.3 95.1 94.9 –
Meta – 81.5 80.3 91.7 81.3 82.7 81.4 92.7
Naive no 92.2 79.3 83.3 92.3 92.6 79.2 86.5
Integr 1 no 95.1 91.6 93.9 95.5 95.5 91.2 95.0
Integr 2 yes 95.4 94.8 95.1 95.4 95.2 94.9 95.1
Integr 3 no 95.0 94.7 94.1 95.3 95.5 91.1 94.9
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Table S5: Point estimate, standard error and 95% Wald CI of model parameters in the confounding
function
Est SE 95% CI
1 φ0 0.040 0.077 (-0.111, 0.191)
Gender φ1 -0.038 0.018 (-0.073, -0.003)
Histology φ2 -0.067 0.015 (-0.096, -0.037)
Race φ3 0.008 0.027 (-0.045, 0.060)
Charlson φ4 -0.014 0.012 (-0.038, 0.009)
Income φ5 -0.001 0.008 (-0.016, 0.014)
Insurance φ6 0.003 0.017 (-0.030, 0.036)
Travel φ7 0.009 0.014 (-0.019, 0.037)
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